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  Objectives 
The thesis will evaluate the catalytic activity and enantioselectivity of native Old 
Yellow Enzyme from S.pastoranius in comparison with three engineered enzyme 
variants. Substrates will be bioactive compounds with a particular emphasis on 
terpenoids and fragrances. 
Methods | Experiences | Results  
 
Three variants and wild type (WT, shown figure up left) Old Yellow Enzyme 
(OYE) from S.pastonarius (OYE1) were used. One mutant, W116I, contained a 
site-directed mutation that changed Trp-116 to Ile. The active site volume was 
increased and resulted in a reveresed enantioselectivity for (S)-carvone 
compared to WT OYE1. Then, cp303 was modified by circular permutation. The 
N- and C-termini were changed but the overall amino acid sequence was kept. 
The flexibility of the enzyme was increased as well as the size of active site 
entrance (see figure bottom right). Previous studies showed faster catalytic rates. 
The last mutant, cp303W116I, is an OYE that combined both peptide alterations 
(no published results). The enzymes were purified from transformed E.coli by 
Anion Exchange Chromatography and Size Exclusion Chromatography. 
Enzymatic assays were done in 200 µL final volume with 1 µM enzyme using 1 
µM phosphite dehydrogenase and 10 mM sodium phosphite as a regenerating 
system and 100 µM NADP+ as cofactor. Time points were taken by extracting 
substrates with organic solvent before being analyzed by chiral GC with an 
optimized method. Results showed that for rigid linear substrates, mutants were 
not efficient, showing no enantioselectivity switch or increase in cataytic rates. It 
was hypothesized that these molecules needed more stabilization in the active 
site in order to be efficiencly catalyzed. However, mutants showed high rates with 
(S/R)-carvone. 
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“Learn from yesterday, live for today, hope for tomorrow. 
The important thing is not to stop questioning.” 
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1. Abbreviations 
Index of the abbreviations used in the text listed in alphabetical order. 
AEX ..................................... Anion Exchange Chromatography 
CP ......................................... Circular Permutation 
cp303 .................................... OYE Circular Permutant n°303 from Daugherty et al.[1] study 
cp303W116I ......................... OYE Circular Permutant plus tryptophan mutant 
CV ........................................ Column Volume 
DMSO .................................. Dimethyl sulfoxide 
DNA ..................................... Deoxyribonucleic acid 
E.coli .................................... Escherichia coli 
EWG .................................... Electron Withdrawing Group 
FAD ...................................... Flavin Adenine Dinucleotide 
FID ....................................... Flame Ionization Detector 
FMN ..................................... Flavin Mononucleotide 
GC ........................................ Gas Chromatography 
IPTG ..................................... β-D-1-thiogalactopyranoside 
kDa ....................................... Kilo Daltons 
LB ........................................ Lysogeny Broth 
MeOH .................................. Methanol 
NADP ................................... Nicotinamide Adenine Dinucleotide 
NaPi ...................................... Sodium phosphite 
OYE ..................................... Old Yellow Enzyme 
OYE1 ................................... Old Yellow Enzyme from S.pastonarius 
PCR ...................................... Polymerase Chain Reaction 
PTDH ................................... Phosphite dehydrogenase 
RT ........................................ Room Temperature 
S.cerevisiae .......................... Saccharmoyces cerevisiae 
SEC ...................................... Size Exclusion Chromatography 
SDS ...................................... Sodium Dodecyl Sulfate 
SDS-PAGE .......................... Polyacrylamide Gel Electrophoresis in presence of SDS 
S.pastonarius ........................ Saccharomyces pastonarius 
W116I .................................. OYE tryptophan mutant from Padhi et al.[2] study 
WT ....................................... Wild Type OYE1 
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2. Introduction 
Nowadays, enzyme mediated biotransformations, which are chemical modifications involving a 
biological catalyst, are very useful and helpful processes. These have several advantages compared to 
chemical transformations, like remarkable chemo-, regio- and stereoselectivity and mild reaction 
conditions (temperature, pH). These properties meet the growing demand for sustainable and cost 
effective “green chemistry” processes. 
Removing or adding an electron to a molecule belongs to the so-called redox reactions. It is one of the 
most investigated topics in biocatalysts research because it may lead to the creation of a chiral center. 
This is happening when the four substituents of a tetrahedral atom (usually carbon) are different. There 
are two possible dispositions of the substituents in space per each chiral center. One is the R and the 
other is the S-enantiomer, depending on the relative position of the substituents. These molecules have 
the same formula and atoms composition. The only detail that differs is the disposition of the 
substituents around a chiral center, which cause them to be the mirror image of each other, like the 
right and the left hand are. All biologically active molecules are chiral, and so are the majority of 
today's drugs [3].  
Two enantiomers have similar chemical and physical properties. However, it is known that their effect 
as drug may be different depending on their different conformation. Thalidomide [4], Naproxen [5] or 
L-α-methyldopa [6] are good examples of why producing enantiopure drugs has become a real 
concern. Enantiomers, obtained by bioreduction, like the Roche-Ester [7, 8], may also be used as 
starting material for several industrially relevant molecules like vitamins, fragrance compounds, 
antibiotics or natural products. 
Today’s helpful molecules are becoming more and more complex, because of the increasing number 
of chiral centers they feature. As seen before, classic chemistry cannot be as efficient as biocatalysts in 
creating enantiopure solutions. Biocatalysis is where the enzymes like the ones from the Old Yellow 
Enzyme (OYE) family found their usefulness. This kind of enzyme is able to reduce activated alkenes, 
which are organic molecules containing a double bonds and an electron withdrawing group (EWG) 
that weaken the double bond. The electron transfer is done with the help of a cofactor incorporated in 
the OYE, which can be: a flavin mononucleotide (FMN), a flavin adenine dinucleotide (FAD) or a 
nicotinamide adenine dinucleotide (NAD(P)). Enzymes are generally efficient for one or a group of 
substrates. Frequently, the enzyme can only either slightly catalyze, or not catalyze at all, the target 
molecule for which it is not adapted. Because of this, the enzyme must be optimized. 
Today, thanks to protein engineering it is possible to modify the amino acids sequence of enzymes in 
order to affect (i.e. improve) their characteristics like their selectivity, their activity or even their 
physicochemical characteristics. The purpose of these modifications is to enhance those small catalytic 
units in order to optimize processes or investigate new synthetic pathways for industrially relevant 
molecules. Usually, changes of enzymatic properties have been recently achieved with different 
techniques, which can be divided into two approaches: rational design and directed evolution. Rational 
design is based on pre-acquired knowledge and focused on deleting, substituting or re-arranging one 
or several amino acids within the protein sequence. 
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Instead, the aim of directed evolution is to try to mimic the effect of evolution on several thousand 
years by using molecular biology and applying a selective pressure to find enzyme with improved 
properties. The effect of these changes within enzyme’s structure are difficult to predict [9] but, it is 
possible to study them through techniques such as crystallography and biophysical methods.  
Recently, a new approach of protein engineering, the circular permutation (CP), has been introduced. 
It is based on the modification of the tertiary structure of an enzyme by re-arranging the overall amino 
acid composition. That means that the overall amino acids composition do not change but the N and 
C-termini are located elsewhere [1].  
The aim of this work is to study the substrate and enantioselectivity of the native OYE from 
Saccharomyces pastonarius and three variants obtained by protein engineering. Wild Type OYE1 
(WT) is 400 amino acids long and weights 40 kDa. The active site is showed in figure 1 where eight 
amino acid side chains are highlighted: Thr–37, Trp-116, His-191, Tyr-196, Asn-194, Phe-250, Phe-
296 and Tyr-375. Most of them are contributing to create a hydrophobic environment in the pocket, 
while others have a bigger importance. Indeed, Massey and Kohli have investigated the role of Tyr-
196 [10], it was suggested that tyrosine 196 helps with the proton transfer during the oxidative half-
reaction with the reduced flavin and an activated alkene. Massey also studied the role of asparagine 
194 and histidine 191 [11]. Those residues were identified to make hydrogen bonds with phenolic 
compounds in order to stabilize them in the active site. 
 
Figure 1: Active site of the Wild Type Old Yellow Enzyme 1 (OYE1) from S.pastonarius. Some amino acids 
that take part to the formation of the active site are highlighted in red. They are close to where the 
substrate binds with the FMN, which is shown on the bottom of the active site pocket. 
The first mutant, W116I, has been modified by site-directed mutagenesis. The tryptophan in position 
116 was replaced by an isoleucine [2] (Trp is showed on the middle right of figure 1). This variant was 
chosen because it showed a change in enantioselectivity by producing enantiomeric products from the 
reduction of (S)-carvone instead of diastereoisomeric products [2]. Padhi et al.[2] made the 
assumption that replacing Trp by Ile permit a new orientation of the (S)-carvone into the active site 
and also increased its volume by allowing the access to a hydrophobic pocket.   
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The second variant is the cp303 and was modified by circular permutation. CP was done with a 
tandem of two attached enzyme genes (oye1 in the figure 2), which were linked with a tri-peptide. 
Then, with a polymerase chain reaction (PCR) technique, it was possible to create various mutants by 
selecting a beginning and an end at different positions on the tandem. The trick resides in designing 
primers that will always give a fragment of the same length (figure 2). Therefore, the overall amino 
acids composition is kept.  
 
Figure 2: Creation of circular permutants of OYE1 [1]. The two genes are plugged together with a nine-
nucleotide sequence encoding the -Gly-Thr-Ser- linker. PCR amplification with site-specific primers will give 
different fragments of same length each (1188 nucleotides) but with different N and C-termini. Picture from 
Daugherty et al [1]. 
One of the variants (cp303) thus obtained was showing significant improvement in activity for (S)-
carvone and ketoisophorone, up to 10 fold higher than the wild type [1]. Statements were that 
removing the loop containing Phe-296 (figure 1) resulted in a significantly higher oxidative half 
reaction rate and in a better flexibility of the enzyme [1]. The opening to the active site was enlarged, 
as it is possible to see in figure 3.  
 
Figure 3: Comparison of the active site entrance between the WT and the circular permuted one. A FMN molecule is shown 
in the bottom of the pocket.   
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The last mutant, cp303W116I is a variant containing the tryptophan mutation as well as the same N 
and C-termini as cp303 (unpublished results). This last mutant was produced assuming it will have 
additives properties with the effect of the site directed mutagenesis as well as the circular permutation. 
In order to investigate the previous statements made on each OYE1 variant, different substrates with 
unique properties will be used. (S/R)-carvone (S/R-1) are molecules that have an industrial interest in 
flavors and fragrances industry [12]. Due to their high volatility, (S)-carvone reduced products, 
(2R,5S)- or (2S,5S)-carvone, respectively (R/S)-2 and (S/S)-2, are used as inhibitors of bacteria and 
filamentous fungi repellents [13]. They are also used as starting compounds in the synthesis of 
bioproducts like antimalarial drugs [14] or valuable chiral synthons (synthetics building blocks) [15, 
16]. Carvone is also used as a reference and control because is one of the most common substrate used 
with OYEs [1, 2, 7]. Trans α-methyl-cinnamaldehyde (3) is a conjugated system, which (S/R)-α-
methyl-dihydrocinnamaldehyde, (S/R)-4 are molecules with an industrial relevance for perfumery as 
starting material for fragrance compounds [17-19]. Myrtenol (5) is a fragrance component used in 
decorative cosmetics (fine fragrance, shampoos, soaps, etc.) as well as in non-cosmetic products like 
detergents or household cleaners [20]. Unlike the others molecules used in this work, myrtenol is not a 
flat component because it contains a bicyclic structure. Because the modifications made on the active 
site of OYE1 [1, 2], it is expected that one of the variants will be able to process that bulky substrate. 
Bioreduction of methyl-2-hydroxymethylacrylate (7) was investigated with OYE1 variants because 
that leads to (R)-Roche-Ester, (R)-8, which is a popular chiral building block for the synthesis of 
various compounds [7, 8]. It can be used to get vitamins (vitamin E [21]), fragrance molecules 
(muscone [22]), antibiotics (calcimycin [23]) and other natural products (spiculoic acid [24]) [8]. 4-
phenyl-3-butyn-2-one (9) contains a triple bond; therefore it is an example for the use of OYE in a 
reaction that implies two consecutives bioreductions. This molecule was chosen because of the 
possibility to compare with previous results from BASF [25].  
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Finally, the (E/Z)-Citral, (E/Z)-12, is another reference substrate as it is a largely used molecule used 
for bioreductions. Furthermore, E-12 (geranial) and Z-12 (neral) forms are two different substrates for 
OYE. The native OYE1 catalyzes the conversion to the enantiopure products (E-12 to (R)-citronellal, 
(R)-13 and Z-12 to (S)-citronellal, (S)-13 [26]). Both enantiomers, (S/R)-13 are used in the synthesis 
of menthol [27].  
 
 
Figure 4: Structure of the substrates used in this thesis. (S/R)-1 is (S/R)-carvone. (R/S)- and (S/S)-2 stands for 
(2R,5S)- and (2S,5S)-carvone. 3 is trans-α-methylcinnamaldehyde. (S/R)-4 is for (S/R)-α-
methyldihydrocinnamaldehyde. 5 is for myrtenol. (S/R)-6 stands for (S/R)-dihydromertanol. 7 is for methyl 2-
hydroxymethylacrylate. (S/R)-8 is for (S/R)-methyl-3-hydroxy-2-methylpropionate “Roche Ester”. 9 is for 4-
phenyl-3-butyn-2-one. (E/Z)-10 is for (E/Z)-4-phenyl-3-buten-2-one. 11 is for 4-phenyl-3-butanone. (E/Z)-12 is 
for (E/Z)-citral, respectively geranial and neral. (S/R)-13 is for (S/R)-citronellal.  
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3. Project objectives 
The goal of this study will be to determine the enantioselectivity and the catalytic activity for wild 
type OYE1 and three engineered variants among a set of various substrates.  
Previous work by Padhi et al. [2] lead to development of the W116I mutant, after it was observed that 
WT was presenting diminished rates for 3-ethyl-2-cyclohexanone (figure 5). It was believed that these 
lower rates were a consequence of unfavorable steric interactions within the active site. In order to 
reduce these interactions, the active site volume was increased. Amino acids residues that were closest 
to the active site were investigated and attention was focused on residues that were within a distance 
of 5 Å of where the substrate binds. Relying on previous studies by Massey [10, 11, 28], the known 
amino acids that are essential for catalytic purposes were removed from the list. From the remaining 
amino acids, Trp-116 was chosen because it was the closest to where the β-substituents of 2-
cyclohexenone were. Several mutations were made, but the isoleucine mutant was kept. The result on 
(S)-carvone showed a switch in enantioselectivity by producing (2S,5S)-carvone as major product 
instead of (2R,5S)-carvone as the wild type does. However, the mutant was not tested against 
substrates significantly different than (S)-1. This work will try to better understand the features of this 
new enzyme as well as possible enantioselectivity switch with other substrates. 
 
Figure 5: 3-ethyl-2-cyclohexenone. 
Circular permutation [29] was used by Daugherty et al. [1] to create a library of OYE variants. In 
order to find mutants with a higher activity among the library, OYE circular permutants were 
synthesized with an in vitro transcription/translation (IVTT) system. This ex vivo protein engineering 
strategy allowed the exploration of a library of hundreds of enzyme variants to highlight the ones with 
a higher activity. Among the selected enzymes, circular permutant #303 (cp303) was found to have an 
increased activity, up to > 10x for (S)-carvone compared to WT. Further studies showed that cp303 
was allowing a faster regeneration of the cofactor. These results were in accordance with previous 
studies [30] that identified the loop region VI (the truncated region, amino acids from 290 to 310) as 
taking part in the reductive half reaction. Also, the active site entrance was significantly increased (see 
figure 3). Through this work, this variant will be tested with different substrates in order to formulate a 
better understanding of the nature of modifications presented in the cp303 scaffold.  
The last variant is an OYE containing the cp303 and the Trp-116 changes. No studies were done on 
this enzyme before the beginning of this work. It has been suggested that this mutant would show 
additives properties regarding cp303 and W116I.  
Other ongoing studies are investigating alternative amino acids positions for site-directed mutagenesis, 
such as an Ala instead of Pro-296 (located in the same region as cp303), which showed an increase in 
conversion rates with (S)-carvone by an order of magnitude about 5x higher than WT (Lutz 
unpublished data based on IVTT system).  
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4. Material and methods 
4.1 Material 
4.1.1 Equipment 
Table 1: Listing of the specific equipment used for this work.  
Model Provider Use 
GenePulser Xcell BioRad 
Electroporation of competent cells 
(E.coli BL21 and DH5α) 
Äkta purifier 
Amersham 
pharmacia biotech 
Anion-Exchange Chromatography to 
purify proteins 
HiTrap Q HP 5 ml (34 µm bead size, 
bed dimension 7x25 mm) 
GE Healthcare Anion-Exchange Chromatography 
Agilent 6850 series 
Agilent 
Technologies 
Gas Chromatography analysis 
Cyclosil-B 
113-6632, 30 m, film 0.25 µM 
Agilent 
Technologies 
Gas Chromatography analysis 
Sonic Dismembrator Model 100 Fisher Scientific Cell lysis in purification step 
Millex-HV (0.45 µm) 
article: SLHV033RS 
Millipore Clean clear lysate in purification step 
Amicon Ultra-15 Centrifugal Filter 
Device 
article: UFC901024 
Millipore 
Concentration of protein before size 
exclusion separation 
HiPrep 16/60 Sephacryl S-100 High 
resolution 120 ml 
GE Healthcare Size Exclusion Chromatography 
Ressource Q 1 ml Pharmacia Biotech Anion-Exchange Chromatography 
Orbital Shaker S-500 VWR Enzymatic Assay 
4.1.2 Cells 
Table 2: Listing of cell lines used in this work. 
Cell line Provider Use 
BL21(DE3)pLysS Invitrogen 
Host cell for the transformation and expression of 
recombinant OYE 
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4.1.3 Reagents 
Table 3: All reagents and chemicals used for the purpose of this work. Table 1/2. 
Substance Provider / Art. / Lot Use 
Bacto™ Peptone Becton Dickinson / 211677 / 2012329 
2YT medium for 
protein expression 
Yeast Extract Fisher BioReagents / BP1422 / 121653 
2YT medium for 
protein expression 
Sodium Chloride Macron / 7581 / 0000038485 
2YT medium and 
purification buffers 
Tris Hydrochloride 1M Solution 
pH 8 
Fisher BioReagents / BP1758 / 135742 Purification buffers 
Benzonase nuclease Sigma / E1014 / SLBJ7662V 
Cell lysis in 
purification step 
Lysozyme Sigma / L-6876 / 127F-81301 
Cell lysis in 
purification step 
Phenylmethylsulfonyl fluoride 
(PMSF) 
Thermo Scientific / 36978 / JL1176862 
Cell lysis in 
purification step 
Isopropanol Fisher Scientific / A451-4 / 115991 SDS-PAGE 
SDS 10% solution Fisher Scientific / BP2436-1 / 044922 SDS-PAGE 
Stacking Gel Buffer (0.5 M Tris 
pH 6.8) 
BioRad / 161-0799 SDS-PAGE 
Resolving Gel Buffer (1.5 M 
Tris, pH 8.8) 
BioRad / 161-0798 SDS-PAGE 
Tetramethylethylenediamine 
(TEMED) 
Fisher BioReagent / BP15020 / 101031 SDS-PAGE 
40% Acrylamide/Bis Solution 
29 :1 
BioRad / 161-0144 / 76782A SDS-PAGE 
Ammonium Persulfate (APS) Fischer Scientific / 106372 / BP179-25 SDS-PAGE 
(S)-carvone Sigma Aldrich / 435759 / MKBD9582V Enzymatic Assay 
(R)-carvone Sigma Aldrich / 124931 / 78897MJV Enzymatic Assay 
  
  
 13/70  
Table 4: All reagents and chemicals used for the purpose of this work. Table 2/2. 
Substance Provider / Art. / Lot Use 
(E/Z)-citral Sigma Aldrich / C83007 / 7819MJ Enzymatic Assay 
(R)-(+)-citronellal Aldrich / 343641 / MKBM0881V 
GC Reference 
molecule 
(S)-(-)-citronellal Aldrich / 373753 / BCBJ9098V 
GC Reference 
molecule 
trans α-methyl-cinnamaldehyde Sigma Aldrich / 112275 / 14719JUV Enzymatic Assay 
3-phenylpropionaldehyde Acros Organics / 24510050 / A0305564 
GC Reference 
molecule 
Myrtenol Wako / 328-53101 Enzymatic Assay 
(+)-trans-Myrtanol Fluka / 70117 / BCBF9640V 
GC Reference 
molecule 
4-phenyl-3-butyn-2-one TCI / P1336 / SAN6M-BJ Enzymatic Assay 
trans 4-phenyl-3-buten-2-one Acros Organics / 164520500 / A0329138 
GC Reference 
molecule 
4-phenyl-2-butanone Acros Organics / 105830050 / A0102795 
GC Reference 
molecule 
Methyl 1-
(hydroxymethylacrylate) 
Combi-Blocks / QB-2069 / L79180 Enzymatic Assay 
Methyl (R)-(-)-β-
hydroxyisobutyrate 
Acros Organics / 436180010 / 339416 
GC Reference 
molecule 
Methyl (S)-(+)-3-hydroxy-2-
methylpropionate 
Alfa Aesar / 44483 / D10Z028 
GC Reference 
molecule 
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4.1.4 Softwares 
Name / Version Developer Use 
Microsoft Excel / 
14.3.8 
Microsoft 
Gas chromatography data analysis, enantiomeric 
excess and quantitative data calculation 
Prism / 6.0e 
GraphPad 
Softwares, Inc. 
Conversion rate calculation and figures creation 
PyMOL / 1.6.0.0 Schrödinger LLC. Figures creation 
GC ChemStation / 
B.03.02 [341] 
Agilent 
Technologies 
Gas Chromatography analysis 
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4.2  Methods 
4.2.1 Cell transformation by electroporation 
Genes of the targeted OYE1 enzymes have been cloned into a pET14b (4.7 kb) vector. This plasmid 
contains a T7 expression system as well as an Ampicillin resistance. It allows the induction of the 
recombinant protein expression by the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG). 
This molecule binds the lac repressor (see figure 6) and leads to the transcription of the regulated gene. 
For a proper expression an E.coli strain containing the DE3 gene (such as the BL21(DE3)pLysS used 
in this work), which carries the information to express the T7 RNA polymerase as well as its 
regulation by the lac promoter. This engineered strain of E.coli allows an increased stability of the 
expressed proteins because is deficient in lon and aspartyl proteases. It also contain a pLysS plasmid 
[31], which is an additional control for the expression of the recombinant gene. It encodes for the T7 
lysozyme, which is a natural inhibitor of T7 RNA polymerase [32].  
 
Figure 6: Control elements of the pET System [32]. 
E.coli BL21(DE3)pLysS competent cells are transformed with pET14b-cpOYE303W116I and 
pET14b-OYEW116I by electroporation. 150 ng of DNA is added to 100 µL of cells before the 
suspension is transferred in the electroporation cuvette. The transformation is performed with one 
pulse (capacitance 25 µF, resistance 200 Ω, 2 mm cuvette) and 1 mL of lysogeny broth (LB, Bacto™ 
Peptone 10 g/L, Yeats Extract 5 g/L, NaCl 10 g/L at pH 7) is immediately added to the cells and 
transferred to a sterile Eppendorf. Then, transformed cells are incubated 30 min at 37°C to allow the 
reconstitution of the membranes and the expression of the genes responsible for the antibiotic 
resistance. Finally, 200 µL are used to inoculate an agar LB plate (containing ampicillin and 
chloramphenicol), which is incubated overnight at 37°C.  
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4.2.2 Overexpression of cp303W116I and W116I 
A single colony of transformed E.coli BL21 is inoculated in 2 mL of LB with antibiotics 
(chloramphenicol and ampicillin at 34 µg/ml and 100 µg/ml respectively) and incubated overnight at 
37°C. Then, the whole volume is used as inoculum for 600 mL of 2YT (Bacto™ Peptone 16 g/L, 
Yeast Extract 10 g/L, NaCl 5 g/L at pH 7). This culture is incubated at 37°C with shaking at 200rpm 
until its optical density at 600nm (OD600) reaches 0.5 – 0.7. Overexpression of the recombinant protein 
is induced by the addition of 1 M IPTG to a final concentration of 0.4 mM for 18 hours at 20°C. After 
that, the cells are harvested by centrifugation at 4°C for 20 min 4000 g. The cell pellet is washed in 20 
mL of buffer A (NaCl 20 mM, Tris-HCl 40 mM at pH 8) in 50 mL Falcon tubes. These tubes are then 
centrifuged with the same conditions as before. Once the supernatant is removed, the cell pellet can be 
stored at -20°C. 
4.2.3 Purification of cp303W116I and W116I from E.coli BL21(DE3) by 
anion exchange chromatography 
OYE enzymes were purified by anion exchange chromatography (AEX). A clear lysate solution was 
obtained by sonication, which promotes the disruption of cell membranes by the generation of sonic 
waves. This phenomenon involves the formation of a vapor phase in a liquid phase, in the same way as 
boiling does. The difference is that it is not the heat that induces vapor formation but high pressures. 
The bubbles, or cavities, formed will implode and generate intense shockwaves when subjected to 
higher pressures [33]. After centrifugation, the clear lysate is harvested and purified through the anion 
exchange column. The stationary phase is functionalized with quaternary ammonium radicals, -NH4+, 
which are strong anion exchanger groups (see figure 7). The capture of OYE1 on the column is 
achieved with the help of negatively charged amino acids (Glu, Asp) regions on the enzyme, which 
will interact with the positively charged stationary phase. Once the column retains the compound, the 
system is washed in order to remove from the column non-specific bound molecules. Then, a gradient 
of a stronger anion competitor (NaCl or KCl) is passed through the system in order to displace the 
molecules attached to the stationary phase. At the column’s end, a spectrophotometric detector that 
can be set to a desired wavelength analyzes the buffers. The flavin cofactor bound in OYE1 enzymes 
has two distinct absorbance peaks at 360 and 460 nm; therefore the elution of the enzyme can be easily 
monitored. In order to follow the presence of the overall proteins, a third wavelength is set at 274 nm. 
 
Figure 7: Diagram showing the anion exchange chromatography principle. In this experiment, the 
immobilized cation surface is made of ammonium groups (-NH4+) and the negatively charged balls 
represents the OYE1.   
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Cell pellet containing an expressed OYE were suspended with a ratio of 1 gcells/6 mL in lysis buffer (1 
mM PMSF, 1750 U benzonase nuclease and 10 mg lysozyme in buffer A) and stored on ice for 30 
min. Cells were kept in ice and lysed by sonication (9x with 10 s pulse and 20 s pause) and cell extract 
was then centrifuged at 4°C for 30 min 16100 g. The clear lysate obtained was loaded at 5 mL/min 
into a pre-equilibrated HiTrap Q FF (5 mL) column with 3 column volumes (CV) of buffer A (Tris-
HCl 40 mM at pH 8; depending on the protein concentration, two of those columns could be plugged 
in series on an Äkta purifier). The column was washed with 2 CV of buffer A until the A274nm was 
stable. The elution of OYE was obtained with a gradient from 0 to 100% in 10 CV of buffer B (1 M 
NaCl, 40 mM Tris-HCl at pH 8), collecting the peak corresponding to the increase in the absorbance at 
360 and 460 nm. The collected fractions were pooled together and concentrated by centrifugation at 
4°C for 20 min, 4000 g with an Amicon Ultra-15 Centrifugal Filter Devices by Millipore (molecular 
weight cut-off: 10 kDa).  
4.2.4 Size exclusion chromatography 
In order to remove the last contaminants, a size exclusion chromatography (SEC) is performed as final 
step. This technique is usually used to remove small contaminants in an already purified solution. 
Through the column, particles will be separated depending on their molecular size. Therefore, it is 
important to notice that this technique is efficient only for molecules with a significant difference in 
their size. The column is packed with porous beads through which small molecules will travel (green 
path on figure 8). Obviously, if a molecule is too large to enter a pore, it will continue to flow through 
the system without being retained (red path). The result of this is that the small compounds have a 
higher retention time than the large ones. 
 
Figure 8: Size exclusion chromatography principle. Small particles (green line) will enter porous beads and 
thus stay longer in the column, while larger molecules (red line) will pass through without being retained. 
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SEC column efficiency can be visualized with selectivity curves. These graphics are obtained by 
plotting the elution volume [mL] against the molecular weight [kDa]. The lines can inform the user on 
the molecular weight range where the column will be efficient. The selectivity curve corresponding to 
the column used in this work (HiPrep 16/60 Sephacryl S-100 High Resolution) is shown in the figure 
9. Knowing that the OYE has an approximate molecular weight of 44 kDa, it should be eluted after 
45-50 ml. 
 
Figure 9: Selectivity curve for globular proteins on HiPrep 16/60 Sephacryl High Resolution columns. 
For a standard run of SEC, the sample must be centrifuged initially at 4°C for 10 min at 16100 g to 
avoid loading precipitated protein in the system. Then, the sample is injected in a HiPrep 16/60 
Sephacryl S-100 High-resolution (160 mL) column, pre-equilibrated in buffer C (300 mM NaCl, 40 
mM Tris-HCl at pH 8). SEC is performed with a constant flow rate of 0.5 mL/min. The OYE detection 
is done the same way as for the AEX chromatography.  
Finally, the protein is split into aliquots by using buffer C as diluent and with a final concentration of 
10% glycerol. Aliquots are stored at -20°C.  
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Introduction
HiPrep™ 16/60 and 26/60 Sephacryl™ S-100 High Resolution,
Sephacryl S-200 High Resolution, and Sephacryl S-300 High
Resolution are prepacked gel filtration columns designed for
preparative purification of proteins and peptides. Sephacryl
HR is a cross-linked copolymer of allyl dextran and
N,N-methylenebisacrylamide. This cross-linking gives the
matrix good ridgity and chemical stability.
Steep selectivity curves give excellent resolution power for
peptides and proteins in the molecular weight range,
Mr 1 000–10 000 (Sephacryl S-100), Mr 5 000–250 000
(Sep acryl S-200), nd Mr 10 000–1 500 000 (Sephacryl S-300).
See Figure 1 and “Column data” for column characteristics.
Fig 1. Selectivity curves for globular proteins on HiPrep 16/60 Sephacryl HR
columns.
Column data
Matrix Cross-linked copolymer of allyl dextran
and N,N-methylenebisacrylamide
Mean particle size 47 µm (25–75 µm)
Separation range (Mr)
globular proteins 1 x 103–1 x 105 (Sephacryl S-100 HR)
5 x 103–2.5 x 105 (Sephacryl S-200 HR)
1 x 104–1.5 x 106 (Sephacryl S-300 HR)
dextrans 1 x 103–8 x 104 (Sephacryl S-200 HR)
2 x 103–4 x 105 (Sephacryl S-300 HR)
Column volume 120 ml (16/60)
320 ml (26/60)
Sample volume1 Up to 5 ml (HiPrep 16/60)
Up to 13 ml (HiPrep 26/60)
Recommended flow rate 15 cm/h at room temperature (0.5 ml/min
for 16/60 or 1.3 ml/min for 26/60)
Maximum flow rate 30 cm/h at room temperature (1 ml/min
for 16/60 or 2.6 ml/min for 26/60)
Maximum pressure over the 0.15 MPa, 1.5 bar, 21 psi
packed bed during operation2
HiPrep column hardware 0.5 MPa, 5 bar, 73 psi
pressure limit2
Theoretical plates >5 000 m-1
pH stability
long term and working range 3–11
short term 2–13
Storage 20% ethanol
1 Optimal sample volume depends on the complexity of the sample, and flow rate. If the
sample contains substances with small differences in size, either decrease sample volume,
or decrease flow rate (in very difficult cases, it may be necessary to decrease both).
2 Many chromatography systems are equipped with pressure gauges to measure pressure at
a particular point in the system, usually just after the pumps. The pressure measured here
is the sum of pre-column pressure, pressure drop over the gel bed, and post-column
pressure. This is always higher than the pressure drop over the bed alone. Keeping the
pressure drop over the bed below 1.5 bar is recommended. Setting the upper limit of the
pressure gauge to 1.5 bar will ensure that the pump shuts down before the gel is over-
pressured. If necessary, post-column pressure of up to 3.5 bar can be added to the limit
without exceeding the column hardware limit. To determine post-column pressure, proceed
as follows:
To avoid breaking the column, post-column pressure must never exceed 3.5 bar.
1. Connect a piece of tubing in place of the column.
2. Run the pump at the maximum flow you intend to use for chromatography.
Use a buffer with the same viscosity as you intend to use for chromatography.
Note the backpressure as total pressure.
3. Disconnect the tubing and run at the same flow rate used in step 2.
Note this backpressure as pre-column pressure.
4. Calculate post-column pressure as total pressure minus pre-column pressure.
If post-column pressure is higher than 3.5 bar, take steps to reduce it (shorten tubing, clear
clogged tubing, or change flow restrictors), and perform steps 1–4 again until the post-column
pressure is below 3.5 bar. Note post-column pressure when it has reached a satisfactory level,
add 1.5 bar to this value, and set this as the upper pressure limit on the chromatography system.
Fi st-time use
The column is sealed with the top and bottom pieces which
support the nylon nets welded to the column tube after the gel
has been packed. Red plastic caps are snapped over both ends
of the column. Do not attempt to remove these caps. The
column cannot be opened, emptied or re-packed.
Connecting the column
1. Before connecting the column to a chromatography
system, start the pump to remove all air from the system,
particularly in tubing and valves.
2. Stop the pump.
3. Mount the column vertically, remove the domed nut, and
connect the inlet tubing to the system “drop-to-drop”.
4. Remove the transport syringe and connect the column
outlet tubing to, for example, a monitor cell. Save the
transport syringe for use when storing the column. The
column is now ready for use.
Equilibration of the column
Ensure an appropriate pressure limit has been set.
Equilibrate the column for first-time use, or after long-term
storage as follows:
1. One-half column volume of distilled water at a flow rate of
15 cm/h (0.5 ml/min for 16/60 or 1.3 ml/min for 26/60).
2. Two column volumes of start buffer, e.g. 0.05 M sodium
phosphate, 0.15 M NaCl, pH 7.2 at 30 cm/h (1 ml/min for
16/60 or 2.6 ml/min for 26/60).
Try these conditions first
Flow rate: 15 cm/h (0.5 ml/min for 16/60,
or 1.3 ml/min for 26/60).
Sample volume: 1% of the column volume
(1.2 ml for 16/60 or 3.2 ml for 26/60)
Buffer: 0.05 M sodium phosphate, 0.15 M NaCl,
pH 7.2 or select the buffer in which the
sample should be solubilized for the next step.
To avoid pH-dependent non-ionic
interactions with the matrix, include at least
0.15 M salt in the buffer (or use buffer with
equivalent ionic strength).
Read the section “Optimization” for information on how to
optimize a separation.
Buffers and solvent resistance
De-gas and filter all solutions through 0.22 µm filter to increase
column lifetime. Buffers and solvents with increased viscosity
will affect the backpressure and flow rate.
Daily use
All commonly used aqueous buffers, pH 3–11
Cleaning
Acetonitrile, up to 30%
Sodium hydroxide, up to 0.5 M
Ethanol, up to 24%
Acetic acid, up to 1 M
Isopropanol, up to 30%
Guanidine hydrochloride, up to 6 M
Urea, up to 8 M
Avoid
Unfiltered solutions
Sample recommendations
Recommended sample load 0.5%–4% of the column
volume (0.6–4.8 ml for 16/60,
or 1.6–12.8 ml for 26/60)
Note: The sample volume is
critical for the separation.
Preparation Dissolve the sample in start buffer,
filter through 0.22 µm filter, or
centrifuge at 10 000 x g for 10 min.
Delivery and storage
The prepacked column is supplied in 20% ethanol. If the
column is to be stored more than 2 days after use, wash the
column with four column volumes of distilled water, and
equilibrate with four column volumes of 20% ethanol.
To avoid air bubble formation in the column, use the transport
syringe. Connect the transport syringe to the capillary tubing
at the column outlet. Start the pump, and fill the syringe to
approximately 50% of the total syringe volume.
DO NOT OPEN THE COLUMN!
Choice of buffer
Selection of buffering ion does not directly affect resolution.
Select a buffer in which the purified product should be
collected, and which is compatible with protein stability and
activity. Buffer concentration must be sufficient to maintain
buffering capacity and constant pH.
Ionic strength should be at least 0.15 M NaCl in the start
buffer, to avoid non-specific ionic interactions with the matrix.
Optimization
Perform a first run as described in the section “Try these
conditions first”. If the obtained results are unsatisfactory,
consider the following:
Action Effect
Decrease flow rate Improved resolution
Decrease sample volume Improved resolution
Figs. 2–5 show the influence of sample volume, flow rate and
sample loading on the resolution
Buffer: 50 mM NaPO4, 0.15 M NaCl, 0.02% NaN3, pH 7.0
Sample: IgG, ovalbumin, cytochrome C, 1:2:1
Flow rate: 0.66 ml/min
Total protein load: 8 mg
Equilibration before a new run
Regenerate the column after each run with one column volume
of start buffer at 25 cm/h (0.8 ml/min for 16/60 or 2.2 ml/min
for 26/60).
Instructions
HiPrep 16/60 or 26/60 Sephacryl S-100 High Resolution
HiPrep 16/60 or 26/60 Sephacryl S-200 High Resolution
HiPrep 16/60 or 26/60 Sephacryl S-300 High Resolution
Inlet tubing, Domed nut,
Unions M6 female/1/16” male
Transport syringe
Fig 2. Resolution (Rs) between IgG and ovalbumin at different sample volumes.
HiPrep 16/60
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4.3 Estimating purity with SDS-PAGE 
A polyacrylamide gel electrophoresis (PAGE) in denaturing condition with the presence of sodium 
dodecyl sulfate (SDS) can give an approximate idea on how pure the solution is. First, the SDS, which 
is an anionic detergent, is used in order to linearize the proteins. It applies negatives charges elsewhere 
on the protein resulting in the straightening of the biomolecule because each charge repulses each 
other of the same sign. Once the SDS linearizes the proteins, they can be separated by their size 
through an acrylamide gel. It works like a grid containing several holes, depending on the percentage 
of acrylamide. The more holes there is, the slower bigger proteins will travel and the fastest the small 
one will migrate through the grid. An electric current going from the negative cathode toward the 
positive anode produces the flow. Since the proteins are negatively charged, they will be attracted 
toward the positive pole. A blue coomassie dye is added to samples in order to be able to follow the 
elution front. When it reaches the bottom of the gel, the migration is stopped. To see the results, the 
gel must be dyed. For this experiment, the gel is stained with a blue coomassie dye. An overall view of 
the migration and coloration is showed by the figure 10. 
 
Figure 10: Overall schematic view of a SDS-PAGE analysis [34]. 
SDS-PAGE gel is prepared in order to get a final 10% acrylamide. Samples (cells after sonication, 
clear lysate, fraction after AEX and fraction after SEC) are mixed with deionized water and 4x SDS 
buffer before being denatured at 95°C for 10 minutes. After loading samples and the markers (Broad 
Range Ladder from BioRad), the gel is run at 200 V for 40 min. For the coloration, the gel is put in a 
box with the staining solution (1 g coomassie blue in 50% methanol) and warmed up in a microwaves 
oven for 30 s at max potency. After that, the gel is destained with a solution of 10% MeOH, 7% 
Glacial Acetic Acid in water. A piece of absorbing paper can be added in the box to trap the 
coomassie. Then, the box is slightly rocked for 5 min before removing the solution. Additional 
destaining steps may be required. When the gel is destained, it is stored digitally using a geldoc imager 
(Biorad). An OYE’s band is visible corresponding to its molecular weight at 44 kDa.   
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4.4 Determination of purified enzyme concentration 
Protein concentration can be calculated by measuring the absorbance in the UV-vis region and 
applying equation 1: 
!! = !! ∙ ! ∙ !↔ ! = !!!! ∙ ! 
Equation 1: Re-arranged Beer-Lambert law in order to be able to deduce concentration of a solution from its 
absorbance. Where Ax [-] is the absorbance at a wavelength of X [nm]. εx is the molar extinction coefficient 
[mM-1*cm-1] at a wavelength of X [nm]. [C] is the concentration of the solution [mM] and L is the length of the 
optical path [cm]. 
However, to use this formula, the molar extinction coefficient of each variant has to be experimentally 
determined. OYE1 has a FMN cofactor bound in its active site with a known extinction coefficient of 
the free form at 450 nm as 11.3 mM-1cm-1. By denaturing the enzyme, the flavin will be released and 
the absorbance of the free cofactor could be measured accurately. Assuming a ratio 1:1 (see equation 
2), the concentration of the enzyme is equal to the concentration of FMN. !"!!"!!"#$!%"& + !"!!"## ↔ !"!!"# 
Equation 2: Stoichiometric equation between the OYE1 with and without its flavin cofactor. 
The molar extinction coefficient of the enzyme is calculated using the equation 1. 
Initially, the enzyme solution is centrifuged at 4°C for 10 min 16100 g. Supernatant is used for the 
measurement of the soluble OYE’s spectrum from 300 to 800 nm. Secondly, the protein is denatured 
by adding 0.5% SDS final concentration and by boiling in the microwave 1 min at max potency. The 
solution is centrifuged at RT for 10 min 16100 g. The free flavin spectrum from is then measured. The 
max absorbances of the OYE1 (~450 nm) and of the free flavin (445 nm) are used for the calculation. 
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4.5 Enzymatic Assays 
Because oxygen can be turned over by the enzyme consuming NADPH, the assays are done under 
anaerobic conditions in a hermetic chamber at room temperature with an orbital agitation. Within the 
reaction, the coenzyme NADPH is recycled by phosphite dehydrogenase, as shown in the following 
figure: 
 
Figure 11: Representation of the enzymatic system applied during this work. The substrate is catalyzed by the 
OYE1 in the left half, while the cofactor is regenerated by the phosphite dehydrogenase in the right half. 
For each measurement, 30 µL of reaction were taken from the reaction vials at pre-determined time 
points. 50 µL of ethyl acetate containing cyclohexanone (GC internal standard) are immediately added 
to quench the enzymatic reaction. The solution was well homogenized by shaking vigorously for 1 
minute. To enhance phase separation, the tubes were centrifuged at RT for 2.5 min and 16100 g. 
Finally, the organic phase was analyzed by GC with the corresponding method. Table 5 shows the 
concentration of each constituent in the reaction vial per substrate. 
Table 5: Composition of enzymatic reactions according to the substrate used. NaPi stands for sodium phosphate. 
NADP+ for Nicotinamide adenine dinucleotide phosphate and PTDH for phosphite dehydrogenase. S/R-1 are for 
S/R-carvone. 3 is for trans α-methylcinnamaldehyde. 5 is for myrtenol. 7 stand for methyl 2-
hydroxymethylacrylate. 9 is for 4-phenyl-3-butyn-2-one and (E/Z)-12 is for E/Z-citral. 
 (S)-1 (R)-1 3 5 7 9 (E/Z)-12 
[Substrate] 200 µM 200 µM 2 mM 500 µM 600 µM 200 µM 600 µM 
[Enzyme] 1 µM 1 µM 1 µM 1 µM 1 µM 1 µM 1 µM 
[NaPi] 10 mM 10 mM 10 mM 10 mM 10 mM 10 mM 10 mM 
[FMN] 5 µM 5 µM 5 µM 5 µM 5 µM 5 µM 5 µM 
[NADP+] 100 µM 100 µM 100 µM 100 µM 100 µM 100 µM 100 µM 
[PTDH] 1 µM 1 µM 1 µM 1 µM 1 µM 1 µM 1 µM 
[Cyclohexanone] 500 µM 500 µM 1 mM 500 µM 500 µM 500 µM 500 µM 
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4.5.1 Calculations of relatives concentrations 
Results shown as relative concentrations are calculated according equation 3. !!!! + !! +⋯+ !! ∙ 100 = !"#$%&'"!!"#!$#%&'%("#!!"!!! ![%] 
Equation 3: Calculation of relative concentration of a compound X in a reaction with N components. 
4.5.2 Calculation of enantiomeric excess 
Enantiomeric excess (ee) are calculated according equation 4. ! − !! + ! ∙ 100 = !!! 
Equation 4: Calculation of the enantiomeric excess for A, which is the predominant specie among products. 
4.5.3 Calculation of conversion rates 
Conversion rates are determined from quantitative data (figures in appendix 10.4.1 to 10.4.6) by using 
the slope of the linear regression of the consumption of substrate. Regressions are done with GraphPad 
Prism 6. !"#$%! !!!"#!$%&$'!"#!!"#$%! ![!"#!!"#$%!] = !"#$%&'("#!!"#$! !!!!"# ∙ !"#!!  
Equation 5: Calculation of conversion rate from the slope of a linear regression of quantitative data of 
components against time. 
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4.6 Gas Chromatography analysis 
Enantioselectivity and catalytic activity were determined following the consumption of starting 
material and the appearance of product by gas chromatography (GC) analysis. This instrument allows 
the separation of components through a capillary column. The mobile phase is a gas (i.e. hydrogen) 
and the compounds are vaporized in the injector so they also enter the system in gas phase. Then, the 
sample arrives in the column, which is installed in an oven. The instrument is programmable allowing 
the creation of defined methods that control the temperature of the system. The operator can choose 
between various modes: isothermal (same temperature over a selected duration of time), gradient 
(temperature increase with a chosen slope) or even a mix of both modes. 
The column used in this work (Cyclosil B, Agilent, 30 m long, 0.25 µM film thickness) is coated with 
30% hepatkis (2,3-di-O-methyl-6-O-t-butyl-dimethylsilyl)-ß-cyclodextrin (figure 12), which is a 
functionalized cyclodextrin.  
 
Figure 12: Scheme of a Heptakis(2,3-di-O-methyl-6-O-t-butyl-dimethylsilyl)-ß-cyclodextrin, which is a 
functionalized cyclodextrin found on a Cyclosil-B (Agilent) stationary phase. 
The principle is very similar to the SEC. Cyclodextrins can be imagined like barrels, which allows 
compounds (usually, the desired analyte) to get in it to form a complex, before being released (figure 
13). This interaction depends on several factors. There are the hydrophobic interactions, the van der 
Waals attractions, any hydrogen bonding or electrostatic interactions that can retain a molecule guest 
inside a cyclodextrin. The molecules that enter the cyclodextrins will travel longer through the column 
than the ones that do not get inside the barrels. The difference of speed obtained between compounds 
will result in a separation of the components throughout the column.  
 
Figure 13: Non-functionalized Cyclodextrin (green barrel) capturing a molecule.   
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At the end of the column, there is a flame ionization detector (FID). As its name suggest, the detector 
uses a flame to ionize analyte molecules coming out of the column. The ions formed then interact with 
the electrodes of the detector to generate electrical signals. This process is depicted in figure 14. 
 
Figure 14: Flame ionization detector scheme. « A » stands for Analyte. Once it is burnt, it releases an electron 
(e-) and thus, become positively charged (A+), those ions are detected by the electrodes in the combustion 
chamber. Then, the electrical detector gives a signal corresponding to the excitation of the electrodes. 
In every sample, an internal standard was added. It is a molecule that does not interact with any other 
component in the injected solution and that is present at the same concentration. The utility of this 
standard is to reduce the impact of the error created by the injector, which does not always inject the 
exact same volume in the column. Since the concentration of internal standard is identical in every 
sample, injector inconsistencies can be overcome by normalizing analyte peak areas relative to the 
internal standard peak areas. Once this is done, areas from separate injections can be confidently 
compared between each other.  
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4.6.1 (S/R)-carvone 
The method is the following:  Start at 90°C and hold 5 min. Then increase temperature 1°C/min until 
120°C and hold for 15 min, total run time of 35 min. Injector and detector are set at 250 and 250°C 
respectively. The H2 flow is set constant at 1.8 ml/min with a front pressure of 36.6 kPa. 1 µL is 
injected with a split of 1:1. Retention times for (S/R)-carvone are 27.5 and 27.6 min respectively. 
(2S,5S)- (2R,5S)-carvone have retention times of 22.9 and 23.1 min, while retention time for (2R,5R)-
carvone is 22.7 min.  
4.6.2 Trans α-methyl-cinnamaldehyde 
The method is the following: Isothermal, 150°C hold 10 min. Injector and detector are set at 250 and 
200°C respectively. The H2 flow is set constant at 1.8 ml/min with a front pressure of 45.7 kPa. 1 µL is 
injected with a split of 25.1:1. The retention time for trans α-methyl-cinnamaldehyde is 6.3 min. S-
cinnamaldehyde has a retention time of 3.8 min.  
4.6.3 Myrtenol 
The method is the following: Start at 90°C and hold for 1 min. Then increase temperature 3°C/min 
until 120°C and hold 19 min, total run time 20 minutes. Injector and detector are set at 250 and 310°C 
respectively. The H2 flow is set constant at 4 ml/min with a front pressure of 71.2 kPa. 1 µL is injected 
with a split of 1:1. Retention time for myrtenol is 11.7 min. (+)-trans-myrtanol has a retention time of 
16.1 min. 
4.6.4 Methyl 2-hydroxymethylacrylate 
The method is the following: Starting at 60°C and hold 1 min. Then, 1°C/min until 75°C, hold 4 min, 
total run time 20 minutes. Injector and detector are set at 280 and 200°C respectively. The H2 flow is 
set constant at 4 ml/min with a front pressure of 68.6 kPa. 1 µL is injected with a split of 1:1. 
Retention times for trans methyl 2-hydroxymethylacrylate is 16.8 min. Methyl (R)-(-)-β-
hydroxyisobutyrate and methyl (S)-(+)-3-hydroxy-2-methylpropionate have retention times of 15.2 
and 17.0 min.  
4.6.5 4-phenyl-3-butyn-2-one 
The method is the following: Start at 70°C and hold 1 min. Then, increase temperature 2°C/min until 
110°C and hold 15 min, total run time 36 minutes. Injector and detector are set at 250 and 310°C 
respectively. The H2 flow is set constant at 4 mL/min with a front pressure of 71 kPa. 1 µL is injected 
with a split of 1:1. Retention time for 4-phenyl-3-butyn-2-one is 23.4 min. For the 4-phenyl-3-butene-
2-one and the 4-phenyl-2-butanone, retention times are 34.6 and 21.9 min.  
4.6.6 (E/Z)-citral 
The method is the following: Start at 80°C, increase temperature 2.5°C/min until 115°C and hold 2 
min, total run time 16 minutes. Injector and detector are both set at 270°C. The H2 flow is set constant 
at 4 ml/min with a front pressure of 68.5 kPa. 1 µL is injected with a split of 1:1. E/Z-citral peaks 
could not be identified because enantiopure solutions are not commercially available. However, the 
separation was possible and the E/Z-mixture gave two peaks, which retention times are 13.1 and 14.9 
min. (S/R)-citronellal retention time are 9.057 min and 9.018 min respectively.   
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5. Results 
5.1 Enzyme purification 
Following expression the harvested cells (6.4 g) were lysed for a final 40 mL of clarified lysate. The 
sample was loaded on the Anion Exchange and purification proceeded as described into the materials 
and methods. Fractions were collected between 80 and 100 mL corresponding to the elution of the 
flavin peak at 460nm. An AEX chromatogram is showed in the figure 40 in the appendix 10.2.  
Harvested fractions were concentrated down and then injected on the SEC. OYE1 elute between 46 
and 55 mL corresponding to a MW of about 88 kDa as OYE1 is a dimer in solution (SEC 
chromatogram showed in figure 41 appendix 10.3).  
Collected protein fractions were loaded on a 10% acrylamide SDS-page gel and migrated for 40 min at 
200 V. OYE’s band is visible at ~44 kDa, consistent with its reported molecular weight. 
 
 
Figure 15: 10% acrylamide SDS-page gel migrated for 40 min at 200 V and stained with coomassie blue. 1) 
Broad Range Ladder from BioRad, 2) Wild Type OYE, 3) cp303OYE, 4) W116IOYE, 5) cp303OYEW116I. 
5.2  Calculation of enzyme concentration 
The molar extinction coefficients of W116I and cp303W116I variants were determined with 
spectrophotometric assays as described in the materials and methods. 
Table 6: Values obtained and used during the experiment for the determination of the molar extinction 
coefficient of W116I and cp303W116I enzymes. Calculations are based on the equation 1. 
!
W116I% cp303W116I%
OYE1!Amax!! 0.116! 0.056!
Free!FMN!A445! 0.0651! 0.0522!
εFMN![mM71cm71]! 12.5! 12.5!
Dil.!Factor! 2! 1!
FMN=OYE1![mM]! 0.0104! 0.0042!
εOYE![mM71cm71]! 11.1! 13.4!
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5.3 Catalytic rate and enantioselectivity of mutants 
Relative concentrations values used for figures 16, 17, 20, 26, 29 and 35 as well as quantitative data 
are shown in appendix 10.4.1 to 10.4.6. 
5.3.1 (S)-carvone 
Both the enzymatic assay and GC method have been previously optimized [1]. The initial 
concentration of 200 µM of substrate was chosen to ensure the most representative conversion in 3 
hours. Retention times were obtained from reference molecules. Quantitative data were calculated 
from a standard curve. However the enantiomericaly pure products of the reaction are not 
commercially available, quantitative data of the products is calculated using (S)-carvone calibration 
curve (which could cause not accurate measures). Figure 16 shows evolution of relative concentrations 
over time. 
 
Figure 16: Conversion of (S)-carvone into (2S,5S)- or (2R,5S)-carvone by WT and its variants. Experiments are 
done in buffer A (20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 200 µM of (S)-1 as starting material using 
phosphite dehydrogenase and NaPi as cofactor regenerating system. 
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Table 7 shows the calculated enantiomeric excess (ee) and conversion rates for (S)-1. 
Table 7: Enantiomerics excess (ee) in percent and conversion rate expressed as !!!!"#∙!"#!!  for each variant with 
(S)-carvone as substrate. 
Enzyme ee Conversion Rate 
Wild Type 91 (R) 3.8 ± 0.3 
cp303 79 (R) 7.5 ± 0.4 
W116I 91 (S) 17.6 ± 2.6 
cp303W116I 88 (R) 13.8 ± 1.1 
5.3.2 (R)-carvone 
Due to the similarities with the other enantiomer, (R)-1, experiments were done with 200 µM starting 
material, 1 µM enzyme and the same time points. As mentioned before, the enantiomericaly pure 
products (2R,5R)- and (2S,5R)-carvone are not commercially available. Therefore, quantitative data of 
the products is calculated from (R)-carvone calibration curve (which could cause not accurate 
measures). Figure 17 shows evolution of relative concentrations over time.  
 
Figure 17: Conversion of (R)-carvone into (2R,5R)-carvone by WT and its variants. Experiments are done in 
buffer A (20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 200 µM of (R)-1 as starting material using 
phosphite dehydrogenase and NaPi as cofactor regenerating system.   
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Table 8 shows the enantiomeric excess (ee) and conversion rates for (R)-1. 
Table 8: Enantiomerics excess (ee) in percent and conversion rate expressed as !!!!"#∙!"#!!  for each variant with 
(R)-carvone as substrate. 
Enzyme ee Conversion Rate 
Wild Type > 99 (R) 4.3 ± 0.3 
cp303 > 99 (R) 2.2 ± 0.2 
W116I > 99 (R) 7.0 ± 0.4 
cp303W116I > 99 (R) 9.1 ± 0.8 
5.3.3 Trans α-methyl-cinnamaldehyde 
The GC method for this molecule was already designed. However, a few adjustments were necessary 
since the last molecule was eluted after 6 min. Thus, the method was shortened to a total run time of 
10 min without affecting the quality of separation. Several concentrations of starting material were 
investigated in order to get a significant consumption over time.  
Concentrations between 200 µM and 10 mM were tested (200, 500 µM and 2, 3, 5, 10 mM). With 3 
under 2 mM, the starting material was consumed too fast to accurately collect data points. At higher 
concentrations, the rates of conversion slowed down suggesting a possible substrate inhibition. 
Considering the 8% yield for the extraction in ethyl acetate, a compromise had to be found in order to 
have a sufficient area (30-200 pA*s) during the GC analysis and enough substrate to let time to get 
accurate time points. 
 
Figure 18: Time point after 90 min of an enzymatic assay using 10 mM trans α-methyl-cinnamaldehyde as 
substrate and 1 µM Wild Type OYE1 as enzyme. The temperature program is 150°C isothermal for 10 min on a 
Cyclosil-B column from Agilent. Retention times are: 1.9 min for cyclohexanone (internal standard), 5 min for 
(S)-cinnamaldehyde and 6.3 min for the starting material. The area of the product is 1.52 pA*s. 
At 2 mM it was possible to observe a 50% conversion after 45 min. Time points were then adjusted to 
0/10/20/45/90 min in order to obtain the most comprehensive data over time. 
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Signal 1: FID1 A, 
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1   1.941 MF    0.0281   45.61774   27.01990 28.04592
   2   5.029 BB    0.0363    1.52078 5.86155e-1  0.93498
   3   6.352 MM    0.0582  115.51521   33.05820 71.01910
 
Totals :                   162.65373   60.66425
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Figure 19: Time point after 45 min of an enzymatic assay using 2 mM trans α-methyl-cinnamaldehyde and 1 µM 
Wild Type OYE1. The temperature program is 150°C isothermal for 10 min on a Cyclosil-B column from 
Agilent. Retention times are: 1.9 min for cyclohexanone (internal standard), 3.8 min for (S)-cinnamaldehyde and 
6.3 min for the starting material. The areas for the cyclohexanone, the product and the starting material are 
44.78, 7.17 and 14.89 pA*s respectively.  
 
Quantitative data is calculated from a standard curve. As before, the products of the reaction cannot be 
purchased, quantitative data of the products is calculated from 3-phenylpropionaldehyde calibration 
curve. This may cause a non-accurate determination of the concentrations of the product. The product 
was defined as (S)-4 because literature [35] was reporting this molecule as only product. Figure 20 
shows evolution of relative concentrations over time.  
 
Figure 20: Conversion of trans α-methyl-cinnamaldehyde into (S)-dihydrocinnamaldehyde by Wild Type OYE1 
and its variants. Experiments are done in buffer A (20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 2 mM of 
3 as starting material using phosphite dehydrogenase and NaPi as cofactor regenerating system.   
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Signal 1: FID1 A, 
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1   1.941 VB    0.0252   44.78482   27.17441 66.98386
   2   3.856 BB    0.0330    7.17498    3.41778 10.73149
   3   6.352 BB    0.0485   14.89932    4.45658 22.28465
 
Totals :                    66.85913   35.04877
 
 
=====================================================================
                          *** End of Report ***
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Table 9 shows enantiomeric excess (ee) and conversion rates for trans α-methyl-cinnamaldehyde. 
Table 9: Enantiomerics excess (ee) in percent and conversion rate expressed as !!!!"#∙!"#!!  for each variant with 
trans α-methyl-cinnamaldehyde as substrate.  
Enzyme ee Conversion Rate 
Wild Type >99 (S) 78 ± 5.9 
cp303 >99 (S) 70.3 ± 3.9 
W116I >99 (S) 68.9 ± 3.4 
cp303W116I >99 (S) 47.7 ± 4.6 
5.3.4 Myrtenol 
Initially, the method was set with an isothermal temperature at 150°C for 45 min. The result gave a 
myrtenol peak eluting within the tail of the solvent peak (figure 21).  
 
Figure 21: Injection of 1 µL from a 200 µM myrtenol solution. The temperature program was 150°C hold for 45 
min on a Cyclosil-B column from Agilent. myrtenol peak is at 2.2 min. 
In order to increase the retention time, the temperature was lowered. Several temperatures were 
investigated, 90°C gave the best results. A slope of 3°C/min from 90 to 120°C was added in order to 
fasten the overall retentions times and peak shape.  
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As shown by figure 22, 5 was eluted at 11.7 min, away from the solvent, the internal standard, and the 
product. 
 
Figure 22: Injection of 1 µL from a 200 µM myrtenol, 200 µM (+)-trans-myrtanol solution containing 500 µM 
cyclohexanone. The temperature program was 90°C hold 1 min, then 3°C/min until 120°C, hold 19 min on a 
Cyclosil-B column from Agilent. Cyclohexanone peak is at 3.1 min, myrtenol peak is at 11.6 min and (+)-trans-
myrtanol peak is at 15.4 min.  
 
All samples were directly diluted in ethyl acetate during the method optimization. Once the GC 
program was set, the extraction from buffer A was investigated. Usually, molecules were well 
extracted from the buffer. However, this was not the case with myrtenol and especially the (+)-trans-
myrtanol: their extractions yielded 19.3 and 7.2 % respectively. Several alternatives were investigated.  
When selecting another extraction solvent, polar solvents could not be used (would be miscible with 
water). Therefore, n-hexanes were chosen because of its non-polar character. This solvent gave a 16.7 
% yield for the extraction of myrtenol from buffer A. This value was lower than with the ethyl acetate, 
(+)-trans-myrtanol was not investigated with this solvent. Secondly, the substrate concentration was 
increased to 1 mM, so the low yield of extraction would be compensated with the high concentration. 
An assay was run with 1 µM WT, 1 mM of myrtanol and the habitual concentration of the other 
components (see table 5). After 3 hours of reaction, the starting material was still not consumed. The 
same assay was ran but with 5 µM of enzyme in order to avoid a possible substrate inhibition. This last 
assay showed the same tendency as the previous one, no myrtenol consumption after 3 hours. Two 
other assays were done at 500 and 200 µM with 1 µM WT and habitual concentration of the other 
components (table 5). No consumption was recorded, neither after 24 h reaction. Enzymatic assays 
were done with 500 µM myrtenol for the other enzymes (cp303OYE, W116IOYE and 
cp303OYEW116I). This concentration was chosen in order to avoid any possible substrate inhibition. 
It resulted in a non-consumption of the substrate after a 3 hours reaction. 
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|- -----|----------|--------|-------------- ------
   1   3.155 BB      0.0887  275.17307 36.03810 Cyclohexanone                                     
   2  11.665 BB      0.0589  186.54907 24.43144 Myrtenol                                          
   3  15.400 BB      0.0935  301.83939 39.53046 (+)-trans-Myrtanol                             
 
Data File C:\CHEM32\1\DATA\LORIC THESIS MYR\EA2000003.D
Sample Name: Mixture 200 uM
Instrument 1 8/7/2014 2:11:31 PM Loric Page 1 of 2
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5.3.5 Methyl 2-hydroxymethylacrylate 
Initially, a standard method with a long run (over 30 min) has been used to evaluate the retention time 
of the molecule. The results showed that the methyl 2-hydroxymethylacrylate was coming off the 
column very early (figure 23) and that the (R)-Roche Ester (reduced form) had a very similar retention 
time. Temperatures had to be lowered in order to increase their retention times and improve their 
resolution. 
 
Figure 23: Injection of 1 µL from a 200 µM methyl 2-hydroxymethylacrylate solution containing 500 µM 
cyclohexanone. The temperature program is 90°C hold for 1 min, then 1°C/min until 120°C hold 19 min on a 
Cyclosil-B column from Agilent. Cyclohexanone peak is at 3.59 min, while methyl 2-hydroxymethylacrylate peak 
is at 5.39 min. The small peak between them is a contamination from the solvent (ethyl acetate). 
An on going problem with the chromatograms was that the peaks were too wide and had significant 
tailing. This was resulting in a low resolution between components with close retention times. In order 
to improve the shape of the peaks, their resolution and their retention times, lower starting 
temperatures were investigated (90, 75, 60°C). As shown by figure 24, it was possible to obtain good 
separation between peaks with the 60°C method. 
 
Figure 24: Injection of 1 µL from a 200 µM methyl 2-hydroxymethylacrylate solution containing 500 µM 
cyclohexanone. 60°C hold 1 min, then 1°C/min to 75°C, hold 14 min on a Cyclosil-B column from Agilent.   
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   3.400         0.0000    0.00000  0.00000 Cyclohexanone                                     
   2   3.590 BBA     0.1664  301.35580 86.18382 ?                                                 
   3   5.393 MM      0.1819   48.31054 13.81618 ?                                                 
   4  12.300         0.0000    0.00000  0.00000 Myrtenol                                          
   5  16.100         0.0000    0.00000  0.00000 trans-(R)-Myrtenol                                
 
Totals :                     349.66634
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   9.942 BB      0.0968  279.38788 81.82088 Cyclohexanone                                     
   2  15.100         0.0000    0.00000  0.00000 methyl (R)-(-)-beta-hydroxyisobutyrate            
   3  16.790 BV      0.1041   62.07494 18.17912 methyl 2-(hydroxymethyl)acrylate                  
   4  17.000         0.0000    0.00000  0.00000 methyl (S)-(+)-3-hydroxy-2-methylpropionate       
Data File C:\CHEM32\1\DATA\LORIC THESIS ROCHE ESTER\P7000001.D
Sample Name: Start material 200uM RE P7
Instrument 1 7/18/2014 3:36:22 PM Loric Page 1 of 2
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Finally, the method was shortened to a 20 min total time without affecting the quality of the separation 
in the following run (see figure 25). All compounds were identified and quantified with the help of 
reference molecules bought from Acros Organics. 
 
 
Figure 25: Injection of 1 µL from a 70 µM methyl 2-hydroxymethylacrylate, 70 µM Methyl (R)-(-)-β-
hydroxyisobutyrate and 70 µM Methyl (S)-(+)-3-hydroxy-2-methylpropionate solution containing 500 µM 
cyclohexanone. 60°C hold 1 min, then 1°C/min to 75°C, hold 14 min on a Cyclosil-B column from Agilent. 
The last parameter to evaluate was the extraction efficiency. 200 µM of 7 and (S/R)-8 were extracted 
from buffer A with ethyl acetate. It yielded to an efficiency of 40%. In order to overcome the 
extraction factor on the area obtained throughout the GC analysis, the starting concentration of 7 was 
increased to 600 µM. It will be the minimum concentration usable to be able to get consistent GC data. 
An enzymatic assay with 1 µM of WT showed that the conversion of the substrate over time is very 
slow. A small proportion of total starting molecule was consumed after 180 min. In order to confirm 
this assumption, the same assay was done with 5 µM enzyme instead. Results were consistent and still 
showed a slow reaction (figure 26). Because of time issues, this substrate was not investigated with 
other variants. Figure 26 shows evolution of relative concentrations over time. 
 
Figure 26: Conversion of methyl 2-hydroxymethylacrylate into (R)-Roche Ester by WT and its variants. 
Experiment is done in buffer A (20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 600 µM of 7 as starting 
material using phosphite dehydrogenase and NaPi as cofactor regenerating system.   
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]       %
----|-------|------|-------|----------|--------|---------------------
   1   9.948 BV      0.1031  270.15222 80.96442 Cyclohexanone                                     
   2  15.205 VB      0.0966   19.82250  5.94079 methyl (R)-(-)-beta-hydroxyisobutyrate            
   3  16.828 BV      0.1057   18.96139  5.68272 methyl 2-(hydroxymethyl)acrylate                  
  4  17.084 VB      0.1049   24.73171  7.41208 methyl (S)-(+)-3-hydroxy-2-methylpropionate      
Data File C:\CHEM32\1\DATA\LORIC THESIS ROCHE ESTER\P7000004.D
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Instrument 1 8/6/2014 7:12:38 PM Loric Page 1 of 2
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Table 10 shows enantiomeric excess (ee) and conversion rate for 7. 
Table 10: Enantiomerics excess (ee) in percent and conversion rate expressed as !!!!"#∙!"#!!  for wild type OYE1 
with methyl 2-hydroxymethylacrylate as substrate. 
Enzyme ee Conversion Rate 
Wild Type > 99% (R) 0.8 ± 0.1 
5.3.6 4-phenyl-3-butyn-2-one 
The first program tried was adapted from the (S)-1 method because no reference about 9 being 
separated with a Cyclosil-B column was found in the literature and that (S)-1 method was the only 
known method. Before starting, a few modifications were done: the initial oven temperature was 
lowered to 70°C instead of 90°C, as well as the final temperature that was lowered to 110°C instead of 
120°C. A lower temperature was set up in order to allow the molecule to stay longer in the column and 
avoid a possible early elution. In order to improve the sensitivity, the detector temperature was 
increased to 310°C, therefore a maximum amount of molecule will be detected at the end of the 
column. The flow rate was not changed and stayed constant at 2 mL/min (46 cm/s).  
 
Figure 27: Injection of 1 µL from a 200 µM 4-phenyl-3-butyn-2-one solution. The temperature program is 70°C 
hold for 1 min, then 1°C/min to 110°C and hold 5min on a Cyclosil-B column from Agilent. Peak at 4.3 min is 
the 1 mM of cyclohexanone, peak at 9.0 min is the DMSO solvent used for the pre-dilution of 9, peak at 43.5 min 
is the 4-phenyl-3-butyn-2-one, its area is 157.01 pA*s. 
DMSO was used during a pre-dilution for this run for solubility tests purpose. Following experiments 
were done without dimethyl sulfoxide without affecting the quality of the separation.  
Separation of 9 in the figure 27 is already acceptable. However, the retention time is long. In order to 
reduce it, the flow was increased to constant rate of 4 mL/min (71 cm/s) and the temperature slope was 
increased from 1 to 2°C/min. The internal standard concentration was adjusted in order to inject an 
amount between 20 and 50 ng to avoid a column overload. 
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   4.326 MM      0.1419  677.88794  1.19887 ?                                                 
   2   6.400         0.0000    0.00000  0.00000 Cyclohexanone                                     
Data File C:\CHEM32\1\DATA\LORIC THESIS PBO\PBO1000002.D
Sample Name: PBO 200 uM
Instrument 1 8/19/2014 5:48:33 PM Loric Page 1 of 2
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The results of the previous modifications are shown in figure 28. 
 
Figure 28: Injection of 1 µL from a 200 µM 4-phenyl-3-butyn-2-one solution. The temperature program is 70°C 
hold for 1 min, then 2°C/min to 110°C and hold 5 min on a Cyclosil-B column from Agilent.  
An assay with 200 µM 9 and 1 µM WT OYE1 gave a full conversion after 180 min. Time points were 
then adjusted to 0/15/45/90/180 min in order to have the most understandable vision of the substrate 
consumption. All compounds were identified and quantified with the help of reference molecules 
bought from Acros Organics. Figure 29 shows evolution of relative concentrations over time.  
 
Figure 29: Conversion of 4-phenyl-3-butyn-2-one into trans 4-phenyl-3-butene-2-one and 4-phenyl-3-butanone 
by WT and its variants. Experiments are done in buffer A (20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 
200 µM of 9 as starting material using phosphite dehydrogenase and NaPi as cofactor regenerating system   
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Sorted By             :      Signal
Calib. Data Modified  :      6/16/2014 7:49:35 PM
Multiplier            :      1.0000
Dilution              :      1.0000
Use Multiplier & Dilution Factor with ISTDs
 
 
Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   6.370 VBA     0.2076  339.98911 58.54673 Cyclohexanone                                     
   2  21.900         0.0000    0.00000  0.00000 4-phenyl-2-butanone                               
Data File C:\CHEM32\1\DATA\LORIC THESIS PBO\PBO8000003.D
Sample Name: PBO 200 uM
Instrument 1 8/19/2014 6:14:39 PM Loric Page 1 of 2
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Table 11 shows enantiomeric excess (ee) as well as the conversion rates for 9. 
Table 11: Enantiomerics excess (ee) in percent and conversion rate expressed as !!!!"#∙!"#!!  for each variant 
with 4-phenyl-3-butyn-2-one as substrate. 
Enzyme 
9 to E/Z-10 E/Z-10 to 11 
ee Conversion Rate ee Conversion Rate 
Wild Type >99 (Z) 50.7 ± 9.7 - 21.7 ± 2.3 
cp303 >99 (Z) 22.9 ± 1.7 - 0.4 ± 0.1 
W116I >99 (Z) 37.7 ± 3.9 - 0.9 ± 0.1 
cp303W116I >99 (Z) 3.5 ± 0.3 - 0.4 ± 0.04 
 
5.3.7 (E/Z)-Citral 
The first method that was used for (E/Z)-12 did not give a proper separation, as it is possible to see in 
figure 30. 
 
Figure 30: Injection of 1 µL of a (E/Z)-12 200 µM solution in a Cyclosil-B column from Agilent. The internal 
standard peak is at 7 min, while the E or Z form of citral comes out after 29 min.  
The program was 70°C, hold 1 min and 1°C/min to 90°C with a final hold of 9 min to a total run time 
of 30 min. The injector and detector temperatures were 180 and 310°C respectively. The split was 
adjusted to 1:1 in order to allow an amount between 20 and 50 ng of compound to be injected in the 
system. The flow rate was kept constant at 4 mL/min (71 cm/s). However, the separation was not 
sufficient to get both forms of the citral, plus the peak had a strong tailing. 
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Use Multiplier & Dilution Factor with ISTDs
 
 
Signa  1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   3.400         0.0000   0.00000  0.00000 Cyclohexanone                                     
   2   7.004 MM      0.2109  228.54234 74.13897 ?                                                 
   3  12.300         0.0000    0.00000  0.00000 Myrtenol                                          
   4  16.100         0.0000    0.00000  0.00000 trans-(R)-Myrtenol                                
Data File C:\CHEM32\1\DATA\LORIC THESIS CITRAL\P1000001.D
Sample Name: EZ Citral 200 uM P1
Instrument 1 7/1/2014 4:21:30 PM Loric Page 1 of 2
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In order to fix these issues, the initial temperature was raised to 80°C and the slope to 2.5°C/min to a 
final temperature of 130°C. As the initial retention time was long, setting up a high slope should allow 
a faster elution of the compound. The other parameters were not changed. Chromatogram is shown in 
figure 31. 
 
Figure 31: Injection of 1 µL of a (E/Z)-12 200 µM solution in a Cyclosil-B column from Agilent. The internal 
standard peak is at 4.2 min, while one of the E or Z form from citral comes out after 13.1 and 14.9 min. The 
program was 80°C as starting temperature, then 2.5°C to 130°C, hold 10 min. 
The separation of the two forms of citral worked with a good resolution. 
Then, (S/R)-13 were injected separately in the column with the same program as for the figure 32. (S)-
13 had a retention time of 9.018 min, while (R)-13 had a retention time of 9.057 min. As expected, the 
mixture of the enantiomers gave a single peak, as showed in figure 32. 
 
Figure 32: Injection of 1 µL of a (R/S)-13 mixture solution at 200 µM in a Cyclosil-B column from Agilent. The 
internal standard peak is at 4.2 min, while the enantiomeric mixture comes out after 9.014 min. The program 
was 80°C as starting temperature, then 2.5°C to 130°C, hold 10 min. 
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Signal 1: FID1 A, 
 
Peak RetTime Type  Width     Area      Height     Area  
  #   [min]        [min]   [pA*s]      [pA]         %
----|-------|----|-------|----------|----------|--------|
   1   4.295 MM    0.1390  258.59869   31.00788 58.38328
   2  13.127 MM    0.1188   70.37141    9.86990 15.88761
   3  14.904 MM    0.1062  113.96266   17.88524 25.72911
 
Totals :                   442.93277   58.76303
Data File C:\CHEM32\1\DATA\LORIC THESIS CITRAL\P1000004.D
Sample Name: EZ Citral 200 uM P2
Instrument 1 8/19/2014 7:16:48 PM Loric Page 1 of 2
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   3.400         0.0000    0.00000  0.00000 Cyclohexanone                                     
   2   4.272 MM      0.1088  324.32574 43.05125 ?                                                 
   3   9.014 MM      0.1302  429.02231 56.94875 ?                                                 
   4  12.300         0.0000    0.00000  0.00000 Myrtenol                                          
Data File C:\CHEM32\1\DATA\LORIC THESIS CITRAL\P13&14000001.D
Sample Name: S+R Citro 200 uM P13
Instrument 1 7/3/2014 10:34:54 AM Loric Page 1 of 2
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Several methods were tried in order to allow the separation of (S/R)-13. First, in order to slow the 
progress of the components in the column, the flow rate was decreased to 2 mL/min (46 cm/s), it did 
not worked and only resulted in thicker peaks. A higher temperature slope could make one of the 
enantiomer to travel faster, so it was increased to 6°C/min between 80 and 130°C. This method gave 
shorter retentions times but it did not improve the resolution between the two enantiomers. A higher 
starting temperature was tried with a program going from 120 to 180°C with a 5°C/min slope, except a 
shorter retention time, still no change was noticed in the separation of (S/R)-citronellal.  
A method from the literature, from Müller et al.[26] paper was tried, even though the column was not 
the same. The program used was starting at 90°C and hold 45 min, then 5°C/min to 120°C and 
40°C/min to 200°C and hold 5 min. The injector and detector were set at 240 and 250°C respectively. 
The flow rate of hydrogen was adjusted at 1.15 mL/min. This method gave thicker peaks and a column 
bleeding at the end of the program (figure 33), still no change in the separation of the enantiomers. 
 
Figure 33: Injection of 1 µL of a (R/S)-13 mixture solution at 200 µM in a Cyclosil-B column from Agilent. The 
internal standard peak is at 10.5 min, while the enantiomeric mixture comes out after 28.9 min. The program 
was the same as used in the Müller et al. paper [26].  
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   3.400         0.0000    0.00000  0.00000 Cyclohexanone                                     
   2  10.556 MM      0.4475  288.52368 44.31234 ?                                                 
   3  12.300         0.0000    0.00000  0.00000 Myrtenol                                          
   4  16.100         0.0000    0.00000  0.00000 trans-(R)-Myrtenol                                
Data File C:\CHEM32\1\DATA\LORIC THESIS CITRAL\P10000001.D
Sample Name: S+R Citro 200 uM P10
Instrument 1 7/2/2014 10:36:38 AM Loric Page 1 of 2
Created with novaPDF Printer (www.novaPDF.com). Please register to remove this message.
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Another method from the literature was tried using the Lorenzo et al. [36] paper even though the 
column used was not the same as the one used in the given method. The program was starting at 45°C 
and holding 6 min, then 2°C/min to 90°C and hold 20 min, then 2°C/min to 180°C and hold 10 min. 
Injector and detector were set at 230 and 280°C respectively. A constant front pressure of 110 kPa was 
used, which corresponds to a 6.2 mL/min (26 cm/s) flow. As shown by the figure 34, this method did 
not improve the quality of the separation. 
 
Figure 34: Injection of 1 µL of a (R/S)-13 mixture solution at 200 µM in a Cyclosil-B column from Agilent. The 
internal standard peak is at 13.6 min, while the enantiomeric mixture comes out after 26.4 min. The program 
was the same as used in the Lorenzo et al paper [36].  
Another way to evaluate a mixture of enantiomers would be with rotation of light measurements. This 
possibility was investigated but it could not be used in this case. Indeed, a concentration is needed for 
polarimetry measurements. As it is not yet possible to separate the enantiomers, it is not possible to 
quantify them. 
Because of planning issues, further GC programs or techniques could not be tested in order to separate 
the (S/R)-13 mixture. Thus, it was decided that only conversions rate would be calculated from the 
consumption of the starting material. Because (E/Z)-12 were not commercially available, it was not 
possible to identify the peaks in the chromatograms. Therefore, conversion rates are calculated from 
the differences between the sums of the areas between both (E/Z)-12 peaks. Starting concentration 
used in the enzymatic assay will be 600 µM because the extraction of (E/Z)-12 from buffer A with 
ethyl acetate yielded to 30%. A first assay with 600 µM of (E/Z)-citral and 1 µM of WT OYE1 gave a 
full conversion after 180 min. Time points were fixed to 0/30/45/60/90 min in order to have the most 
representative use of the substrate. 
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Signal 1: FID1 A, 
 
Peak RetTime  Type   Width     Area      Area    Name
  #   [min]          [min]   [pA*s]        %
----|-------|------|-------|----------|--------|---------------------
   1   3.400         0.0000    0.00000  0.00000 Cyclohexanone                                     
   2  12.300         0.0000    0.00000  0.00000 Myrtenol                                          
   3  13.630 MM      0.2838  246.64037 41.19155 ?                                                 
   4  16.100         0.0000    0.00000  0.00000 trans-(R)-Myrtenol                                
Data File C:\CHEM32\1\DATA\LORIC THESIS CITRAL\P11000001.D
Sample Name: R+S Citro 200 uM P11
Instrume t 1 7/2/2014 12:18:50 PM Loric Page 1 of 2
Created with novaPDF Printer (www.novaPDF.com). Please register to remove this message.
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Figure 35 shows evolution of relative concentrations over time. No product was detected for variants 
cp303 and cp303W116I. Hence, their concentration is relative to the average concentration of (E/Z)-
12 at t = 0 min. 
 
Figure 35: Conversion (E/Z)-citral into S/R-citronellal by WT and its variants. Experiments are done in buffer A 
(20 mM NaCl, 40 mM Tris-HCl, pH 8 at 20°C) with 600 µM of (E/Z)-12 as starting material using phosphite 
dehydrogenase and NaPi as cofactor regenerating system 
Table 12 shows conversion rates for (E/Z)-citral. 
Table 12: Conversion rate expressed as !!!!"#∙!"#!!  for each variant with (E/Z)-citral as substrate. 
Enzyme Conversion Rate 
Wild Type 29.3 ± 1.8 
cp303 8.1 ± 0.9 
W116I 9.6 ± 0.7 
cp303W116I 5.8 ± 0.7 
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6. Discussion 
6.1 (S)-carvone 
As Stewart reported [2], W116I mutant showed reversed enantioselectivity with an ee (S) of 91% for 
(S)-1 compared to WT possessing an ee (R) of 91%. The substitution of Trp at position 116 positions 
(S)-carvone in a flipped conformation compared to WT. It was also reported that the Trp replacement 
enables the isoprenyl substituent of (S)-1 to adopt a different conformation due to the substitution of 
Trp to a smaller amino acid, as shown in figure 36.  
 
Figure 36: Position of S-(1) in the active site of W116I. Replacement of Trp-116 by Ile allows (S)-1 to bind in a 
flipped conformation compared to WT. Residues in the active site pocket are the same as in figure 1. 
While a molecule may bind in many different conformations, not all binding events are catalytically 
productive. One can reason, the W116I mutation alters the active site, and increases enzyme 
performance (almost 5x faster than WT), due to more productive binding events. (S)-1 enters the 
W116I mutant in the flipped conformation (compared to WT), which is optimal for the reduction 
chemistry. Thus it is resulting in a faster conversion for flipped (S)-1 thus more (S/S)-2 is produced 
than (R/S)-2. The same phenomenon may happen for WT, but in this case, the positioning of the (S)-
carvone in the original conformation is converted faster than when it is positioned in a flipped 
conformation, resulting in an enantioselectivity of 91% for (R/S)-2. 
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For the circular permutant (cp303), the conversion rate was faster than WT by 2x. As stated by 
Daugherty et al. [1], this permutant had an increased reductive-half reaction rate, which allows faster 
FMN cofactor regeneration. Regarding the permutant’s enantioselectivity, an ee of 79% for (R/S)-2 
was calculated. In addition to the preserved R-enatioselectivtiy, an overall performance increase was 
observed in cp303 as stated in previous work [1]. 
The last mutant, cp303OYEW116I showed a conversion rate 3.6x higher than WT OYE1 and nearly 
identical to OYEW116I. The enantioselectivity did not switch from (R/S)-2 to (S/S)-2, as expected. 
Instead, an ee of 88% for (2R/5S)-carvone was calculated. The W116I enantioselectivity improvement 
was expected to transfer to the cp303 permutant. However the original WT preference was observed, 
at an improved rate. By cutting the loop in the region VI (amino acids from 289 to 309 [37]), the Phe-
296 is absent in cp303, modifying substrate binding. It is possible that the isoprenyl substituent is in 
the vacant position near Phe-296. In order to get more data about the substrate binding mode, further 
studies are necessary. 
6.2  (R)-carvone 
As previously stated by Padhi et al. [2], the enantioselectivity for (R)-1 did not switched with W116I 
and resulted in an ee > 99% (R/R)-2. The same selectivity was found for all the OYEs tested in this 
work.  
As shown in figure 37 and from these results, tryptophan does not play an important role in the 
positioning of (R)-1 in the active site, as it is the case for (S)-1. However, differences in conversion 
rates were observed. Even though W116I did not showed a reversed enantioselectivity, its conversion 
rate was higher than the WT by 1.6x, however is not as significant for efficient catalysis of (R)-1. 
However, since the rate is higher without tryptophan, it may be possible that Trp-116 stereochemically 
impede the positioning of (R)-1 in the active site of WT.  
 
Figure 37: Induced fit docking of (R)-1 with W116I. Some residues of the active site are shown in ball and stick 
form. Light green molecule is the (R)-carvone in its most favorable complex. Depicted black sticks show the 
experimental structure of WT. Figure from Padhi et al. [2]   
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The conversion rate with cp303 was 2x lower than the wild type. According to figure 37, it can be 
supposed that the loop VI region is important in the stabilization of the substrate in the active site. The 
isoprenyl substituent of (R)-carvone is orientated towards Phe-296, which is absent in the cp303 
variant. Without this part of the loop, it is possible that (R)-1 cannot effectively bind the FMN 
cofactor.  
The cp303W116I variant showed the highest conversion rate (table 8): it was 2.1x higher than WT. 
This result shows that even if loop VI is cut, (R)-1 can still be more efficiently catalyzed. As seen 
before, Phe-296 is missing in this mutant, thus the substrate should not bind effectively in the active 
site, however improved activity was observed. It is possible that the substitution in addition to the CP 
force a new positioning of (R)-carvone. It can be suggested that the isoprenyl substituent of (R)-1 
could be placed in the supplementary hydrophobic pocket (as showed in figure 36) and that the high 
rate could be a consequence of the rapid diffusion of (R)-1 into the active site due to the increased 
entrance. However, further investigations are required. 
6.3 Trans α-methylcinnamaldehyde 
All investigated OYEs yielded same product, without any switch in enantioselectivity, catalyzing the 
transformation of 3 into (S)-4 with an ee > 99%. 
Concerning the catalytic rates, WT had the fastest, cp303 and W116I equally suffered 10% loss in 
activity, while cp303W116I lost 40%. Changes in structure may explain these differences. A previous 
study by Stueckler et al. [35] showed how 3 is positioned in the active site of OYE from S.cerevisiae 
(figure 38). Even though it is not exactly the same enzyme, a major part of the components in the 
active site are conserved among species. Thus, it can be used for comparison purposes. 
 
Figure 38: Active site of OYE from S.cerevisiae. Amino acids side chains are shown in green. FMN is in yellow. 
Dashed lines from 3 represent hydrogen bonding interactions with the cofactor, Asn-194 and His-191. The line 
between Tyr-196 and 3 represent a close contact (3.4 – 3.8 Å). Figure from Stueckler et al. [35] 
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As shown by the previous figure, the aromatic ring of 3 binds above Thr-37 suggesting no interactions 
with Trp-116. The substrate lies above FMN, mainly interacting with His-191 (Massey stated this 
position has an important role in hydrogen bond formation with phenolic compounds [11]), Asn-194 
and Tyr-196. Substituting the tryptophan for isoleucine in W116I slightly reduces the conversion rate 
by 12%. Trp-116 seems to not interact in a significant way in the positioning of 3. Changing this 
amino acid to an Ile and enlarging the active site does not seem to be useful. It is possible 3 has less 
interactions with the cofactor, thus more time is needed for reduction. The indole ring of Trp-116 
might be useful in keeping the molecule as it is in figure 38. 
The circular permutant cp303 truncated loop VI containing Phe-296, resulting in a 10% decrease in 
conversion rate compared to WT. The flexibility conferred to this permutant did not seem beneficial to 
active site interactions for 3, having a similar rationale to W116I. Even if Phe-296 does not interact 
with 3, the loop truncation may slightly perturb the efficient binding of 3 into the active site.  
Mutant cp303W116I posses both previously mentioned changes in its structure, and understandably 
had similar lower catalytic rates. Substituting Trp-116 and truncating VI loop may enable catalytically 
unproductive flexibility for interactions with 3, explaining reduced activity.  
Since no enantioselectivity switch was observed, it is suggested that the modifications made to OYE 
did not had an effect on the positioning of 3 in the active site as (S/R)-1 did. It is possible the other 
active site substitutions would alter orientation of 3 to improve enantioselectivity and/or the catalytic 
rate.  
6.4 Myrtenol 
The reduction of 5 by the OYE wild type and the variants tested was not successful. The starting 
material was not consumed after 24 hours with WT. The variants, cp303, W116I and cp303W116I 
also did not show any consumption of the starting material after 6 hours. Goretti M. et al. [38] 
hypothesized a metabolic pathway for the reduction of (R)-myrtenal within a whole cell system (figure 
39).  
 
Figure 39: Metabolic pathway of (R)-myrtenal used as substrate with a whole cell system involving non-conventional yeast 
cells. Figure by Goretti M. et al.[38] 
According to this figure, 5 cannot lead to the (S/R)-6 as expected. This is only possible if the alcohol 
functional group was first oxidized into an aldehyde, thus reducing the double bond of OYE is 
possible before the ketone is reduced into an alcohol. Such transformations are possible in a whole cell 
system because of the presence of many different enzymes. 
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Such transformations are possible in whole cell systems, because of the presence of other enzymes. 
However, since 5 was not consumed by the OYEs investigated in this work can bring positives 
arguments to the assumptions made for in this pathway.  
An alternative experiment would be the transformation from (R)-myrtenol to (S/R)-6 in a one-pot, 
three step reaction, by adding an aldehyde and alcohol dehydrogenases to the system. These enzymes 
would be able to oxidize the alcohol into an aldehyde, allowing the reduction of the double bond by 
OYE1 before the aldehyde dehydrogenase reduces the functional group back to an alcohol. 
6.5 Methyl 2-hydroxymethylacrylate 
Conversion rate for 7 was the slowest observed in this work. Only WT was investigated, at a 5x higher 
concentration than usual, and it gave a rate of 0.7 !!!!"#∙!"#!!  with an enantioselectivity of >99% for 
(R)-8. 
A previous study done by Stueckler et al. [8] also showed a slow conversion with OYE1. It converted 
7% of 10 mM 7 over 24 hours at 30°C with NAD+ as cofactor and a glucose dehydrogenase recycling 
system, resulting in an observed conversion rate of 0.35 !!!!"#∙!"#!! . However, the difference between 
the two conversion rates could be due to the fact that Stueckler’s reaction was done at 30°C and with 
NAD+ as cofactor. Studies have been done about the difference in affinity between NADH and 
NADPH for WT. Results (Lutz unpublished data) showed that KM,NADPH was 70x lower than KM,NADH, 
thus even at higher reaction temperatures, the rate obtained by Stueckler is lower than the one obtained 
in this present work. Because of the cofactor difference and the temperature change, a direct 
comparison of conversions rates is difficult to assess. 
Stueckler also showed that using a modified 7 did not improve the conversion for OYE1. Three 
derivatizations of 7 (allyl, benzyl and a tert-butyldimethylsilylto) on the single bonded oxygen of the 
carboxylic acid (see 7 in figure 4) were done. O-allyl-7 gave 5% conversion after 24 hours, while O-
benzyl-7 and O-tert-butyldimethylsilyl-7 gave 3 % and non-detectable amounts respectively. These 
results show that the structure of 7, even modified, is not optimal for the active site of OYE1. In order 
to increase the conversion rate of OYE1 with 7, it may be advantageous to focus studies on optimizing 
the shape of the active site. 
6.6 4-phenyl-3-butyn-2-one 
No switch in enantioselectivity was observed all OYEs tested gave >99% (Z)-10 enantioselectivity 
from the conversion of 9. However, diverse conversion rates were obtained for the first reduction on 9. 
The highest was with WT. Next was cp303, which showed half of WT’s rate, while W116I was a bit 
more efficient with a reduction of 26% compared to wild type. The worse case was with cp303W116I, 
which showed an activity lowered by 93% from the WT. 
These results show that increasing the active site volume by removing Trp-116 has reduced the 
conversion rate. It is possible that tryptophan’s indole ring was interacting with the substrate, 
stabilizing its position above the FMN cofactor 
. 
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A similar rational can be made with the cp303 mutant. When the loop VI is truncated, the conversion 
rate is reduced by half meaning that the amino acids removed were interacting in some ways with 9 
and helping in the bioreduction process. A flat and rigid substrate like 9 needs to be held properly in 
order to be reduced by OYE1. Changing the active site did not result in an improvement in catalysis. It 
can be stated that allowing too much freedom for the substrate movement is not helpful in the case of a 
flat molecule. A similar tendency was observed with 3.  
An argument can be made that cp303W116I has the most freedom for the 9 into the active site. This 
mutant showed additive properties regarding the conversion rate. By taking both mutations from 
cp303 and W116I for 9, this enzyme showed a poor conversion rate.  
The second step, involving the reduction of (E/Z)-10 into 11 showed overall lower conversion rates 
than with the first step. At this point, a first assumption can be made by saying that the affinity of the 
enzyme for 9 is higher than for (E/Z)-10. The tendency for decreased catalytic rates for each enzyme 
followed the one stated previously for the conversion of 9 to (E/Z)-10, thus same conclusions can be 
made. 
6.7 (E/Z)-citral 
WT and W116I mutant were the only enzymes with detectible product formation. The two other 
OYEs, cp303 and cp303W116I consumed (E/Z)-12, however no (S/R)-13 was detected. No 
enantioselectivity could have been determined for (E/Z)-12 because reference molecules were not 
commercially available. However, conversion rate can be discussed. Native OYE1 gave the highest 
conversion rate, meaning that the modifications done on the structure of OYE1 were not helpful in any 
way for the bioreduction of (E/Z)-12. 
Padhi et al. tested (E/Z)-12 with W116I and did not report a significant conversion over time [2]. In 
this work, this mutant was converted to (E/Z)-citral 68% slower than WT OYE1, which is supported 
by previous studies. The cp303 OYE1 was less efficient by 73% compared to WT. These two mutants 
showed that the modifications in the active site perturbed the efficiency of the catalysis. Citral is also a 
flat molecule like 3 and 9, meaning that the previous statements made for these molecules can also be 
applied with (E/Z)-12. 
As expected, cp303W116I showed additives properties with a significantly lower conversion rate, 
which was 81% lower than WT. Opening the active site with cp303 and removing Trp-116 with 
W116I leaded to changes that probably perturb the positioning of (E/Z)-12 into the active site.  
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7. Conclusion 
With the exception of myrtenol, which was not consumed by any enzymes tested, and methyl 2-
hydroxymethylacrylate, which was giving very slow conversion rates, this work permits a synopsis of 
the general behavior for the OYEs mutants tested. Indeed, except for (S/R)-1, the variants did not 
show any switch in enantioselectivity or better conversion rates than WT. 
W116I is a mutant where Trp-116 is replaced by an Ile, allowing access to a hydrophobic pocket, 
while cp303 is an enzyme where the loop VI is truncated, allowing greater enzyme flexibility as well 
as a bigger active site entrance. When both modifications were united into cp303W116I, the active site 
has the biggest volume from all the other variants, in addition to an increased flexibility. All planar 
substrates, like trans α-methyl-cinnamaldehyde, 4-phenyl-3-butyn-2-one and (E/Z)-citral gave the 
same tendency among the conversion rates obtained. For all of these molecules, WT obtained the best 
rates, while W116I and cp303 were not significantly different from each other but always lower than 
WT when cp303W116I, showed additives properties by consistently giving the worse conversion 
rates. 
In a general view, it can be hypothesized that for planar molecules the changes made allowed a degree 
of freedom in the active site that was prohibiting effective catalysis. These substrates may need an 
active site that orients them specifically over the FMN cofactor in order to allow an efficient 
reduction. 
For (S)-1, W116I showed a reversed enantioselectivity with an enantiomeric excess of 91% for (S/S)-2 
as well as the highest catalytic rate for this substrate. A possible cause for this high rate is that the 
flipped conformation in which (S)-1 was binding in W116I was also more optimal than the natural 
binding mode thus switching the enantioselectivity. However, this switch was not observed with (R)-1, 
even though the conversion rate was the highest with W116I, and suggested a more optimal 
positioning of (R)-carvone over FMN. The circular permutant cp303 gave a higher conversion rate 
than the wild type but always lower than W116I for (S/R)-1, this mutant did not changed the 
enantioselectivity. Finally, cp303W116I showed a conversion rate close to the W116I for (S)-1, while 
it was the highest for (R)-1, supposing that the huge active site entrance was allowing (R)-1 to take a 
conformation that is significantly more optimal than with WT. However, this last mutant did not show 
any change in enantioselectivity for both (S/R)-1.  
The results presented above suggest that it would be beneficial to investigate substrates that are more 
“carvone-like”, for example: 2-methyl-2-cyclohexenone, perillaldehyde or cyclohexenone. These 
compounds could help give additional credit to the arguments about W116I and cp303 (as well as 
cp303W116I) being better designed to give enhanced responses with stereochemicaly occupied 
molecules while planar substrates would display decreased efficiency. The myrtenol was one of the 
molecules that could give interesting results concerning the substrate positioning. The conversion of 
myrtenol could also if it is used with other enzymes in order to follow the pathway suggested by 
Goretti et al. [38]. Finally, in depth kinetic data (Km, Vmax) could be determined by using different 
concentrations of enzyme in order to have a better understanding and complementary information 
about the mutant’s catalytic activity.  
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10. Appendix 
10.1 Recipes for reagent used during the experiment 
Following recipes are listed in the order of appearance in the text.  
Table 13 shows the recipe for the LB and 2YT medium. 
Table 13: Composition of LB and 2YT mediums used during the transformation and the 
overexpression respectively. 
Component LB 2YT 
Bacto™ Peptone 10 g/L 16 g/L 
Yeast Extract 5 g/L 10 g/L 
NaCl 10 g/L 5 g/L 
pH 7 7 
 
Table 14 shows the recipe for the buffers used during the chromatography steps. 
Table 14: Composition of the buffers used for the purification of cp303W116I and W116I. 
Buffer Sodium Chloride Tris Hydrochloride pH 
A 20 mM 40 mM 8 
A (desalted) - 40 mM 8 
B 1 M 40 mM 8 
C 300 mM 40 mM 8 
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Table 15 shows the recipe for the making of two SDS gel 10% acrylamide with 0.75 mm plates from 
BioRad. 
Table 15: Recipe for the preparation of two SDS gel with a final concentration of 10% acrylamide. 
 Reagent Quantity 
R
un
ni
ng
 g
el
 Deionized water 3.5 ml 
Acrylamide 40% 2 ml 
Buffer 1.5 M Tris, pH 8.8 2 ml 
SDS 10% 80 µl 
APS 10% 80 µl 
TEMED 8 µl 
S
ta
ck
in
g 
ge
l Deionized water 3.15 ml 
Acrylamide 40% 0.5 ml 
Buffer 0.5 M Tris, pH 8.8 1.25 ml 
SDS 10% 50 µl 
APS 10% 50 µl 
TEMED 5 µl 
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10.2 Anion Exchange Chromatography 
 
Figure 40: Anion Exchange Chromatography purification of OYEW116I from cell lysate on a HiTrap Q FF (5 
mL) column. The purple line is the OD460nm, red line is the OD360nm. Green line represents the gradient in 
percent. Values are given against a volume pumped into the system with a flow rate of 5 mL/min. Injection 
stands at v = 0 mL. The flow through is between 0 and 50 mL, while the OYEW116I elution begins at ~80 mL. 
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10.3 Size Exclusion Chromatography 
 
Figure 41: Purification of OYEW116I mutant from cell lysate on a HiPrep 16/60 Sephacryl S-100 column (160 
mL) with a flow rate of 0.5 mL/min.. The purple line represents the OD460nm, red line is the OD360nm. The 
Injection is at v = 0 mL. Elution of the protein of interest after ~46 mL. 
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10.4 Relatives concentrations and quantitative additional data 
10.4.1 (S)-carvone 
Relative concentrations (average on three values) used for figure 16 for the conversion of (S)-carvone.  
Enzyme Time points [min] (S)-carvone (2R,5S)-carvone (2S,5S)-carvone 
W
ild
 T
yp
e 
0 100 0 0 
15 96.3 3.6 0 
45 88.6 11.3 0 
90 66 34 0 
180 33 64.5 3 
cp
30
3 
0 100 0 0 
15 92 8 0 
45 56 39 4.5 
90 26 66.5 7 
180 13 79 8 
W
11
6I
 
0 100 0 0 
15 51.5 47.5 2 
45 12.5 84.5 3 
90 3.6 92.3 4 
180 1.3 95 3.6 
cp
30
3W
11
6I
 
0 100 0 0 
15 78.5 19.5 0 
45 30.5 65.5 4 
90 17.5 78 5 
180 2 93 5 
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Quantitative data plotted against time for (S)-carvone. 
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10.4.2 (R)-carvone 
Relative concentrations (average on three values) used for figure 17 for the conversion of (R)-carvone.  
Enzyme Time points [min] (R)-carvone (2R,5R)-carvone (2R,5S)-carvone 
W
ild
 T
yp
e 
0 100 0 0 
15 86.5 13.5 0 
45 61.3 38.6 0 
90 30.3 69.6 0 
180 0 100 0 
cp
30
3 
0 100 0 0 
15 90.3 9.6 0 
45 72.3 27.6 0 
90 56.3 43.6 0 
180 27.6 72.3 0 
W
11
6I
 
0 100 0 0 
15 80.3 19.6 0 
45 37.6 62.3 0 
90 26.3 73.6 0 
180 5.6 94.3 0 
cp
30
3W
11
6I
 
0 100 0 0 
15 52 48 0 
45 3 97 0 
90 3 97 0 
180 0 100 0 
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Quantitative data plotted against time for (R)-carvone. 
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10.4.3 Trans α-methyl-cinnamaldehyde 
Relative concentrations (average on three values) used for figure 20 for the conversion of trans α-
methyl-cinnamaldehyde. 
Enzyme 
Time points 
[min] 
trans α-methyl-cinnamaldehyde (S)-dihydrocinnamaldehyde 
W
ild
 T
yp
e 
0 100 0 
10 91.6 8.3 
20 88 12 
45 76.6 23.3 
90 42.3 57.6 
cp
30
3 
0 100 0 
10 90 10 
20 88.3 11.6 
45 77 23 
90 49 51 
W
11
6I
 
0 100 0 
10 92 8 
20 88.3 11.6 
45 77.6 22.3 
90 34 66 
cp
30
3W
11
6I
 
0 100 0 
10 97.6 2.3 
20 94 6 
45 79 21 
90 61.5 38.5 
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Quantitative data plotted against time for trans α-methyl-cinnamaldehyde. 
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10.4.4 Methyl 2-hydroxymethylacrylate 
Relative concentrations (average on three values) used for figure 26 for the conversion of methyl 2-
hydroxymethylacrylate. 
Enzyme Time points [min] methyl 2-hydroxymethylacrylate (R)-‘Roche Ester’ 
W
ild
 T
yp
e 
0 100 0 
60 97.6 2.3 
120 93.3 6.6 
180 84.6 15.3 
 
Quantitative data plotted against time for methyl 2-hydroxymethylacrylate. 
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10.4.5 4-phenyl-3-butyn-2-one 
Relative concentrations (average on three values) used for figure 29 for the conversion of 4-phenyl-3-
butyn-2-one.  
Enzyme 
Time points 
[min] 
4-phenyl-3-butyn-2-
one 
trans 4-phenyl-3-butene-2-
one 
4-phenyl-2-
butanone 
W
ild
 T
yp
e 
0 100 0 0 
15 21 77.6 2 
45 0 46.3 53.6 
90 0 4 96 
180 0 0.3 99.6 
cp
30
3 
0 100 0 0 
15 83 17 0 
45 56.6 56.6 0 
90 0 84.3 15.6 
180 0 75 25 
W
11
6I
 
0 100 0 0 
15 73 27 0 
45 36.6 56.6 6.6 
90 8.5 70.5 20.5 
180 2.5 61 36.5 
cp
30
3W
11
6I
 
0 100 0 0 
15 100 0 0 
45 85.3 14.6 0 
90 72 28 0 
180 41.5 58.5 0 
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Quantitative data plotted against time for 4-phenyl-3-butyn-2-one. 
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10.4.6 (E/Z)-citral 
Relative concentrations (average on three values) used for figure 35 for the conversion of (E/Z)-citral. 
Enzyme Time points [min] (E/Z)-citral (S/R)-citronellal 
W
ild
 T
yp
e 
0 100 0 
30 84.3 15.6 
45 71 29 
60 66.3 33.6 
90 35.6 64.3 
cp
30
3 
0 100 0 
30 85.6 0 
45 81 0 
60 80.3 0 
90 71 0 
W
11
6I
 
0 100 0 
30 96.6 3.3 
45 95.6 4.3 
60 93.6 6.3 
90 87 13 
cp
30
3W
11
6I
 
0 100 0 
30 93.3 0 
45 91.3 0 
60 86 0 
90 76 0 
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Quantitative data plotted against time for (E/Z)-citral. 
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10.5 Equipment pictures 
10.5.1 Anion and Size exclusion Äkta module 
 
Figure 42: Äkta purifier from Amersham pharmacia biotech. 
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10.5.2 Gas Chromatography 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 43: Gas Chromatography apparel used for this work. Agilent 6850 Series. 
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10.5.3 Anaerobical chamber 
 
Figure 44: Anaerobical chamber from Coy Laboratories. 
 
